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ABSTRACT
UPPAL, HARJOT An Analysis of Patients Undergoing Hip and Knee Arthroplasties in an Accountable
Care Organization. Department of Gender, Sexuality and Women’s Studies, March 2020.
ADVISOR: DR. MELINDA GOLDNER

Background. Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are commonly
performed procedures, with over one million executed each year in the United States (U.S.)
(Steiner et al., 2012). By 2030, THA and TKA are projected to become the most frequently
performed elective surgical procedures in the U.S. (Cram et al., 2012; Kurtz et al., 2009). Many
of the previous studies on THA and TKA procedures have focused on women, primarily because
they are at increased risks of developing knee osteoarthritis and sustaining hip fractures
(Cummings et al., 1990; Hedlund et al., 1987; Hinton et al., 1995; Myers et al., 1991; Ray et al.,
1997; Schrøder & Erlandsen, 1993; Srikanth et al., 2005). However, there is increasing evidence
suggesting that there are differences in postoperative outcomes between male and female patients
undergoing these procedures (Dalury et al., 2009; Dzupa et al., 2002; Elliott et al., 2003; Endo et
al., 2005; Fox et al., 1994; Fransen et al., 2002; Lavernia et al., 2009; Lim et al., 2015;
MacDonald et al., 2008; Ritter et al., 2008; Schrøder & Erlandsen, 1993; Trombetti et al., 2002).

Purpose. To compare post-surgical outcomes after THA and TKA procedures between male and
female patients part of a physician-led Accountable Care Organization (ACO) participating in
the Medicare Shared Savings Program (MSSP) located in the western U.S. and to determine
whether this MSSP ACO has been successful in decreasing these patients’ total costs of health
care.

Methods. The physician-led MSSP ACO provided cost and health risk data on their male and
ii

female beneficiaries who underwent THA and TKA procedures between the years 2016 and
2018. Health risk data only analyzed patients during the postoperative period. One hundred fiftysix men and 291 women were analyzed in this study.

Results. Most patients who underwent THA and TKA procedures between 2016 and 2018 in this
MSSP ACO had Medicare insurance (n=329; 81.7%) and were predominantly Non-Hispanic
White (n=365; 81.7%). Over three years (2016-2018), men had a greater average risk
stratification score than women (17.7 vs. 15.7), indicating that men undergoing THA and TKA
procedures have worse overall health than women undergoing the same procedures. Women had
greater total costs of health care than men between 2016 and 2017; however, in 2018, men had
greater total costs of care than women. When the patient sample was divided by insurance types,
Medicare-only patients had lower total costs of care than dual-eligible patients-those with both
Medicare and Medicaid insurance- for all three years. Over the three years, the MSSP ACO was
successful in decreasing the total costs of care for its male and female patients who underwent
THA and TKA procedures (5.66% and 18.4%, respectively). Also, Medicare-only patients’
average total cost of care decreased by 11.47%, and dual-eligible patients’ average total cost of
care decreased by 20.7%.

Conclusion. Male sex/gender was linked with worse health after undergoing THA and TKA
procedures. This MSSP ACO was able to decrease its beneficiaries’ total costs of care over three
years. Thus, MSSP ACOs may show promise in reducing health care costs for their beneficiaries.
Policymakers should offer more support to MSSP ACOs for helping them realize increased
revenues.
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PREFACE AND INTRODUCTION
Healthcare is in the midst of a seismic shift, moving from a reimbursement model that
rewarded providers for the volume of services they provided to one focused on the value patients
receive from their care. Now, what does “value” mean? Value-based health care delivers the best
possible outcomes to patients for the lowest possible costs. To adapt to the changing healthcare
environment, health care organizations must develop strategies aimed at reducing their costs
while improving their patients’ outcomes.
The basis for this research stemmed from my desire to study high-cost surgical
procedures commonly performed across all communities in the United States. My senior thesis
analyzes total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures because
there has been significant health reform aimed at improving surgical outcomes and decreasing
costs for Medicare beneficiaries undergoing these procedures. Through this original study, I
analyzed whether there were any sex/gender-specific differences between male and female
patients undergoing THA and TKA procedures between the years 2016 and 2018 in an
Accountable Care Organization (ACO) participating in the Medicare Shared Savings Program
(MSSP). In addition, I analyzed whether this ACO was able to lower its beneficiaries’ total costs
of care over these three years.
It is my hope that the work described here will help give researchers, policymakers, and
clinicians a baseline set of estimates and a more comprehensive understanding of how patients’
sex/gender influences their health care spending and post-surgical outcomes so that the future
effects of health care reform can be adequately evaluated and implemented.

vi

CHAPTER 1: LITERATURE REVIEW
SEX VS. GENDER
The American Medical Association (AMA) Manual of Style defines sex as the “biological
characteristics of males and females” and views gender as “includ[ing] more than sex and serves
as a cultural indicator of a person’s personal and social identity” (Young, 2007, p. 1). Sex
describes the differences between men and women that are primarily biological in origin, and
gender describes differences that are produced by social norms regarding the sexes (Buvinić et
al., 2006). Simply put, sex is determined by chromosomes, and gender is determined by how one
presents oneself in society (American Academy of Orthopaedic Surgeons, 2019).
SEX AND GENDER AFFECT HEALTH OUTCOMES
Even though the concepts of sex and gender can be differentiated using the AMA’s
definitions, it is difficult to determine whether sex or gender affects a patient’s medical
condition. Because most peoples’ gender identities align with their sex, it is nearly impossible to
separate whether an observed difference between men and women is caused by sex or gender
(Dusenbery, 2018). In some cases, differentiation is apparent. For example, there is a higher
incidence of lung cancer in men than women in the United States (U.S.) because men tend to
smoke more cigarettes (Dusenbery, 2018). Clearly, the gender differences between men and
women are causing the increased rate of lung cancer in men. Men are not more biologically
susceptible to lung cancer; they had differing levels of exposure that caused the disease
(Dusenbery, 2018).
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On the other hand, there are sex chromosomal abnormalities, such as Swyer Syndrome,
that are caused by a gene mutation in the Y chromosome. Because only males have a Y
chromosome, Swyer syndrome affects only males (Michala et al., 2008). Clearly, sex differences
in males are the cause of Swyer syndrome in men and boys.
However, most health conditions patients experience are not linked to an apparent
biological or environmental cause (Dusenbery, 2018). Instead, sex and gender can act
independently or synergistically in determining a patient’s burden of disease (Krieger, 2003). For
example, sex and gender differences cause higher rates of osteoporosis in women (FaustoSterling, 2005). The level of bone density in individuals is affected by numerous factors such as
hormones (Chehab et al., 1997; Damien et al., 1998; Ducy et al., 2000), diet (Boot et al., 1997;
Bryant et al., 1999; McKay et al., 2000), physical activity (Messier et al., 2000; Morel et al.,
2001; Pettersson et al., 2000), predisposed genetic background (Aloia et al., 1996; Boyden et al.,
2002; Dibba et al., 1999; Khosla et al., 2008), vitamin D production (Fujita et al., 1999), and
bone-destroying effects of drugs such as cortisone (Larsson, 1969), tobacco (Pocock et al.,
1989), and alcohol abuse (Laitinen & Välimäki, 1991). Thus, our experience directly affects our
biology (Dusenbery, 2018). For this reason, this manuscript will use the term sex/gender while
discussing differences between men and women.
WHY IS SEX/GENDER IMPORTANT IN RESEARCH?
One of the major difficulties in determining the impact of sex/gender on the diagnosis
and treatment of musculoskeletal (MSK) conditions such as osteoarthritis is rooted in how
clinical research is conducted. Even though there have been calls for equal representation for
women in clinical trials (National Institutes of Health, 1994), women continue to be
underrepresented in many areas of clinical research (Geller et al., 2006; Harris & Douglas, 2000;
2

Mogil & Chanda, 2005; Murthy et al., 2004; Ramasubbu et al., 2001; Simon, 2005; Stewart et
al., 2007; Vidaver et al., 2000). This underrepresentation may be due to the barring of pregnant
women from clinical studies for safety purposes, but it may also be due to the differences in
recruiting methods that are causing fewer women to be enrolled in them (Vidaver et al., 2000).
However, even if women are represented in clinical studies, many of the studies do not
perform a gender-specific analysis because they do not have the statistical power-the ability of a
study to detect a difference if a difference truly exists- to allow for this analysis or it was not part
of the hypothesis test being studied (Geller et al., 2006, Harris & Douglas, 2000). Ramasubbu et
al. (2001) found that only 24.6% of clinical trial participants in studies published by the New
England Journal of Medicine were women. Among these trials, only 14% performed a genderspecific analysis. Geller et al. (2006) found that among federally-funded studies published in
major peer-reviewed journals in 2004, only 37% of the participants were women, and genderspecific analyses were performed in only 13% of the studies. This lack of gender representation
and gender analysis could potentially lead to serious consequences. For example, in 2005, 80%
of prescription drugs were withdrawn from the U.S. market because they caused statistically
greater health risks for women than men (Simon, 2005). Thus, what is suitable for men does not
seem to be necessarily ideal for women. However, it is important to note that underrepresentation
in clinical studies does not only pertain to women. According to the American Academy of
Orthopaedic Surgeons (2019), males have not been included in clinical studies analyzing
osteoporosis or hip fractures. Historically thought of as a “disease of postmenopausal women,”
osteoporosis also affects men, who typically develop this disease ten years later than females
(American Academy of Orthopaedic Surgeons, 2019).
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PREVALENCE OF THA AND TKA PROCEDURES
Total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures have a high
prevalence, with over one million performed each year in the U.S. (Steiner et al., 2012). By
2030, THA and TKA are projected to become the most common elective surgical procedures
performed in the United States (Cram et al., 2012; Kurtz et al., 2009). Furthermore, TKA and
THA ranked seventh and twelfth, respectively, among the most common procedures performed
by orthopedic surgeons in 2003 (Garrett et al., 2006). The increase in the prevalence of THA and
TKA procedures performed are attributed to the aging of the “Baby Boomers,” higher rates of
diagnosis and treatment of advanced arthritis, and growing demand for improved mobility and
quality of life (Maradit et al., 2015). Evidence suggests that there may be differences in patient
outcomes after receiving THA and TKA procedures due to sex/gender differences in the
anatomy of the hip and knee joints and underlying disease conditions (Rand et al., 2003). For
example, men display larger knee cartilage volumes and surface areas (Faber et al., 2000) and
have taller and narrower pelvises than women (Wang et al., 2004) (Appendix 1). However, even
with the presence of surgical outcome differences, most patients achieve significant long-lasting
improvements with THA and TKA procedures.
WHY IS SEX/GENDER IMPORTANT IN ORTHOPEDIC SURGERY IN THE UNITED
STATES?
Even though the utilization rates of THA and TKA are increasing at an unprecedented
rate, there exist sex/gender differences between male and female patients undergoing these two
procedures due to the interplay of biologically determined and socially derived differences
between them. For example, women are usually older than men when undergoing THA and TKA
procedures (Figure 1).
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Figure 1. Prevalence of Total Knee Replacement (TKR) and Total Hip Replacement (THR)
by Race and Age. (Maradit-Kremers et al., 2015).
As discussed later in this chapter, sex/gender plays a crucial role in orthopedic surgery,
particularly in the delivery of THA and TKA procedures to patients. Sex/gender differences
affect every stage of a patient’s disease process, from increasing the risk of developing a
musculoskeletal (MSK) disease to increasing the revision and mortality rates after undergoing
THA and TKA procedures. For THA and TKA procedures, revision surgeries are performed to
replace implants, either hip or knee, that are no longer functioning properly (Merriam-Webster,
2020). These sex/gender differences between men and women also affect access to, quality of,
and costs associated with receiving THA and TKA procedures. Because of the substantial
increase in demand for THA and TKA procedures, it is expected that the sex/gender disparities
faced by patients will be exacerbated; therefore, attention will be given to THA and TKA
procedures. The discussion will now move to analyze the sex/gender differences between male
and female patients undergoing THA and TKA procedures.
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Sex/gender is vital in orthopedic surgery because the MSK systems of males and females
are different. For example, women have less muscle mass and different muscle fiber composition
than men (American Academy of Orthopaedic Surgeons, 2019). If men and women have
different MSK systems, why would orthopedic surgeons apply a “one size fits all” mindset to
orthopedics?
JOINT ARTHROPLASTY VS. JOINT REPLACEMENT
Before discussing the sex/gender differences between men and women undergoing THA
and TKA procedures, it is crucial to understand the differences between joint arthroplasty and
joint replacement. Arthroplasty means “the surgical repair of a joint,” and it is a surgical
procedure in which a patient’s arthritic or damaged joint is removed and replaced with a metal,
plastic, or ceramic device called a prosthesis (Stanford Health Care, 2019). Total joint
replacement is a type of arthroplasty (Stanford Health Care, 2019). Thus, this manuscript will
use the words “replacement” and “arthroplasty” interchangeably when discussing the sex/gender
differences in hip and knee arthroplasty procedures. Also, for this manuscript, total joint
arthroplasty encompasses THA and TKA procedures. However, it is important to note that
replacement surgery can be performed on other joints, as well, including the ankle, wrist,
shoulder, and elbow.
Numerous studies presented in this manuscript analyze the sex/gender differences
between male and female patients undergoing THA or TKA procedures. Thus, a brief discussion
of total hip replacement and total knee replacements is needed to ensure that readers understand
what procedures are being discussed in the studies. After addressing total hip replacement and
total knee replacement surgical procedures, the discussion will move to talk about the sex/gender
differences between men and women undergoing THA and TKA procedures.
6

TOTAL HIP REPLACEMENT VS. PARTIAL HIP REPLACEMENT
Hip replacements are divided into two types: total hip replacement (THR) and partial hip
replacement. The human hip is composed of the femoral head (single ball), which is the upper
end of the femur and the acetabulum (joint socket), which is part of the pelvic bone (Figure 2).

Figure 2. The Articulating Surfaces of the Hip Joint-Pelvic Acetabulum and Head of the
Femur (TeachMeAnatomy, 2019).
The bone surfaces of the femoral head and acetabulum are covered with articular cartilage, a
smooth tissue that cushions the ends of the bones and enables them to move easily. In a THR, the
femoral head and articular cartilage are removed and replaced with prosthetic components.
However, in a partial hip replacement, only the patient’s femoral head is removed and replaced
with a prosthetic femoral head (Figure 3).
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Figure 3. The Difference Between a Partial Knee Replacement and a Total Knee Replacement
(Khoo Teck Puat Hospital, 2019).
TOTAL KNEE REPLACEMENT VS. PARTIAL KNEE REPLACEMENT
Like hip replacements, knee replacements can be divided into two categories: total knee
replacement and partial knee replacement. The knee is separated into three main compartments:
the medial tibiofemoral compartment (inner half of the knee), the lateral tibiofemoral
compartment (outer half of the knee), and the patellofemoral compartment (behind the knee cap)
(Figure 4).
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Figure 4. The Three Compartments Inside the Knee (Hoffman Arthritis Institute, 2019).
In a TKA procedure, all three compartments are removed and replaced with a prosthesis, while
in a partial knee replacement, only one knee compartment is removed and replaced with a new
prosthesis (Figure 5).

Figure 5. Difference Between Total Knee Replacement and Partial Knee Replacement (Khoo Teck
Puat Hospital, 2019).
WHAT IS OSTEOARTHRITIS?
Osteoarthritis, sometimes referred to as degenerative joint disease or degenerative
arthritis, is a chronic (long-term) disease. In healthy joints, cartilage covers the ends of each bone
9

and provides a smooth, gliding surface for joint motion. Cartilage acts as a cushion between the
bones. However, in osteoarthritis-stricken joints, cartilage breaks down, causing pain, swelling,
and problems moving the joint (Arthritis Foundation, 2019).
As osteoarthritis worsens over time, bones may break down and develop growths called
spurs. Bits of bone or cartilage may chip off and float around in the joint. In the body, an
inflammatory process occurs and cytokines (proteins) and enzymes develop that further damage
the cartilage. In the final stages of osteoarthritis, the cartilage wears away, and bone rubs against
bone, leading to joint damage and more pain (Arthritis Foundation, 2019).
Osteoarthritis is the most common chronic joint condition, affecting approximately 27
million Americans (Arthritis Foundation, 2019). In the U.S., osteoarthritis is one of the leading
causes of disability. Apart from being the most common form of arthritis, it affects people from a
broad age group, especially those aged 65 years and above (Boyan et al., 2013).
Osteoarthritis can affect any joint, but it occurs most often in knees, hips, lower back and
neck, small joints of the fingers, and the bases of the thumb and big toe (Arthritis Foundation,
2019). The prevalence of knee and hip osteoarthritis is high, with 50% of adults developing
symptoms of knee osteoarthritis, and 25% developing symptoms of hip osteoarthritis during their
lives (Arthritis Foundation, 2019). As seen in Figure 6, osteoarthritis is the most common
underlying condition for both THA and TKA procedures.
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Figure 6. Number of Arthroplasties Performed for Different Diagnoses from 1975 to 2015
(Robertsson, 2019).
SEX/GENDER DIFFERENCES IN PATIENTS UNDERGOING THA AND TKA
PROCEDURES
Even though THA and TKA procedures are beneficial treatments for osteoarthritis and
degenerative joint disease (de l’Escalopier et al., 2016; National Institutes of Health, 2003), there
remains geographical, racial, and sex/gender variations in its utilization (Dunlop et al., 2008;
Ibrahim, 2017; Weng & FitzGerald, 2006). These variations in care utilization are complex and
encompass patient-level factors (patient’s treatment preferences and anatomy), provider-level
factors (physician-patient relationship), and system-level factors (access to specialist care)
(Ibrahim, 2017).
This chapter aims to show the sex/gender differences between male and female patients
undergoing THA and TKA procedures. It will have five main themes: sex/gender differences in
the epidemiology of musculoskeletal (MSK) conditions, sex/gender differences in the access to
THA and TKA procedures, sex/gender differences in the quality of care of THA and TKA
11

procedures, sex/gender differences in the cost of THA and TKA procedures, and a discussion on
health policy related to these sex/gender differences in these two procedures. This chapter
utilizes evidence from peer-reviewed journal articles and government databases to review what is
currently known based on these themes.
THEME 1: SEX/GENDER DIFFERENCES IN THE EPIDEMIOLOGY OF MSK
CONDITIONS
Differences in patients’ sex/gender have been shown to play a significant role in
determining the epidemiology of THA and TKA procedures (Hame & Alexander, 2013;
Nicolella et al., 2012; United States Bone and Joint Initiative, 2014). The sex/gender differences
in the epidemiology of hip and knee arthroplasty procedures have been divided into sex/gender
differences in the prevalence, severity, and progression of musculoskeletal (MSK) conditions.
SEX/GENDER DIFFERENCES IN THE PREVALENCE OF MSK CONDITIONS
Musculoskeletal (MSK) conditions, including osteoarthritis, back and neck pain, and
osteoporosis, are ubiquitous, affecting individuals across their lifespan. According to the Centers
for Disease Control and Prevention (2016), MSK conditions affect one-half of all adults in the
U.S. and three-quarters of those aged 65 and older, making these conditions more common than
hypertension, diabetes, and cardiovascular disease. However, females bear a disproportionate
risk of developing an MSK condition as compared to males. In 2015, 65.6 million females
(52.7%) and 58.8 million males (47.3%) reported having at least one MSK condition (Centers for
Disease Control and Prevention, 2016). The prevalence of all the major MSK conditions—
lumbar back pain, chronic joint pain, arthritis, neck pain, and lower back pain spreading to the
knee—was higher in women than in men (Weinstein, Yelin, & Watkins-Castillo, 2018).
12

Srikanth et al. (2005) conducted a meta-analysis to determine sex/gender differences in
osteoarthritis. Although their study established that there was no significant difference in the
incidence of certain osteoarthritis types such as hand osteoarthritis between sex/gender, women
had a significantly higher prevalence of knee and hip osteoarthritis when compared to men.
Similarly, Hame & Alexander (2013) report that osteoarthritis of the knee affects women
disproportionately when compared to men. Also, there are specific joints in women that are more
susceptible to MSK diseases than in men. For instance, the first carpometacarpal joint (located in
the wrist) is more likely to be affected in women aged above 40 when compared to their male
counterparts (Sodha et al., 2005). Similarly, Hame & Alexander (2013) found that specific joints
in the knee, such as the patellofemoral joint, are more likely to be affected by MSK disease in
women than men.
Female sex hormones are the main factor influencing joint health (Liu et al., 1996;
Stevens-Lapsley & Kohrt, 2010), and differences in sexual hormones between men and women
expose the latter to a higher risk of developing osteoarthritis. Numerous factors are classified as
risk factors of osteoarthritis. The main risk factors include previous knee trauma, obesity, age,
and female sex (Blagojevic et al., 2010). The higher prevalence of arthritis in women than men is
multifactorial: notably, alterations of hormonal levels, especially estrogen, that affect B and T
cell homeostasis and interferon regulation, which increases the risk of arthritis (Templeton &
Watkins-Castillo, 2014). Estrogen can be found in articular cartilage, which makes it hormonally
sensitive.
Women with XbaI and PvuII (PX) haplotype sites located in their estrogen receptor
(ERα) genes have an increased risk of having osteoarthritis than other women (Albagha et al.,
2001; Dong et al., 2008; Gonnelli et al., 2000). A haplotype refers to a set of alleles at linked loci
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(location on a chromosome) that are present on one of two homologous chromosomes
(Bergstrom, 2001); thus, for any given stretch of chromosomal DNA, an individual will have two
haplotypes (Carter et al., 2013). The distribution of the PX haplotype allele is thought to be
genetically influenced because women from different geographical localities exhibit different
distributions of them (O'Connor, 2006). Women have also been recorded as having less thickness
of the cartilage in the distal femur, which may be attributed to the increased risk of osteoarthritis
(O'Connor, 2006).
The increased incidence of osteoarthritis also evidences the impact of female sex
hormones on osteoarthritis after menopause. Men have a higher prevalence of osteoarthritis than
women before the age of 50 (Wilson et al., 1990), but after this age, the prevalence is higher in
women (McAlindon et al., 1992; Oliveria et al., 1995). The prevalence increases with age in both
men and women, but in women, it increases dramatically around the age of 50 (Wilson et al.,
1990; Lawrence et al., 1996; Hernborg et al., 1973), which coincides with menopause. Although
there is no consensus about the mechanical role of estrogen in the prevention of osteoarthritis,
estrogen decreases cartilage damage and subchondral bone loss in the patella and tibia (Sniekers
et al., 2010). As women approach menopause, they have an increased risk for joint arthroplasty,
which can be associated with reduced exposure to estrogen, especially after menopause. The
estrogen-associated risk for joint arthroplasty is higher for the hip joint than the knee. The use of
menopausal hormone therapy was also found to increase the risk of joint arthroplasty. Both
estrogen-only and estrogen and progestin therapies elevated this risk (Liu et al., 2009). The onset
of menopause in women leads to changes in their hormone exposure and contributes to a
heightened risk of osteoarthritis.
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Besides the higher risk for osteoarthritis faced by women as a result of their biological
differences from men, women may be exposed to even higher risks as a result of the early onset
of menopause and menstruation. Studies have shown that a later age at natural menopause is
associated with less loss of bone density and a reduced risk of osteoporosis and fracture (KritzSilverstein & Barret-Connor, 1993; Parazzini et al., 1996; Van Der Voort et al., 2003). Also,
Hellevik et al. (2017) established a negative relationship between older age at menarche (the first
occurrence of menstruation) and the risk of joint replacement. Although the researchers did not
have a conclusive explanation for this relationship, they speculated that early age of menarche
was associated with chronic and widespread MSK disorders. However, the age of menarche only
influenced TKA and was not associated with THA (Hellevik et al., 2017). Interestingly, Starvou
et al. (2002) observed that women who were PX homozygotes had approximately eight months
of delay in menarche compared with those who were PX heterozygotes and subjects without the
PX allele. Thus, the PX haplotype polymorphism may be a genetic determinant of the age of
menarche.
Unlike Hellevik et al. (2017), who found the age of menarche to have no relationship
with THA, Liu et al. (2009) found it to influence both THA and TKA. According to them,
women whose age of menarche was 11 years or younger were at an increased risk of
osteoarthritis and hip and knee replacement than those reporting menarche at age 12 (not age 12
or greater). Even then, the risk for total joint arthroplasty surgery was higher for the knee joint
than the hip joint, though the underlying factors are unclear. One of the explanations for the
heightened risk of osteoarthritis with lower age of menarche could be the differences in body
weight index (BMI). Liu et al. (2009) reported that women who reported menarche at 11 years
and younger had a higher BMI than those reporting at age 12 (not age 12 or greater) (Liu et al.,
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2009). Although there exists conflicting evidence, weight gain at a young age has been observed
to be a significant risk factor for total joint arthroplasty due to osteoarthritis later in life (Apold et
al., 2011; Apold et al., 2014;).
There also exist differences in the morphological characteristics of the distal femur,
patella, and proximal tibia between men and women. The ratio of the size of the femoral
component to the size of the medial-lateral dimension is larger in women than in men, which
exposes their knee joints to increased risks of pain and dysfunction (O'Connor, 2006). A study by
Tummala et al. (2018) affirms these findings in a study to determine sex/gender differences in
knee joint congruity. The study found that women had a higher contact area and significantly
lower congruency indexes in the medial tibiofemoral joint when compared to men. The higher
cartilage–cartilage contact area in women was established pre- and post-radiographic
osteoarthritis, suggesting a likely contributor to the higher reduction in cartilage volume among
women compared to men. The joint incongruence was also seen as contributing to the higher
incidence of radiographic osteoarthritis risk among women (Tummala et al., 2018). Sex/gender
differences in the formation of joints expose women to a higher risk for osteoarthritis than men.
In addition to the hormonal factors and morphological characteristics, the higher lowerextremity-injury rate and lower muscle strength in women when compared to men are thought to
contribute to their higher rate of osteoarthritis (Templeton & Watkins-Castillo, 2014). Hame &
Alexander (2013) also report anatomical and kinematic differences to contribute to the higher
prevalence of knee osteoarthritis in women when compared to men. Women have narrower
thighbones, thinner kneecaps, and larger quadriceps angles than men. This makes them have
lower total tibial and patella cartilage volume, which increases the likelihood of defects
associated with knee osteoarthritis. The loss of knee cartilage volume among women is also
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higher than in men, which increases the development of these defects. Besides, women record
greater posterior and anterior shear forces when performing activities such as jumping, which
can lead to abnormal stress on the knees and increase the risk of knee osteoarthritis (Hame &
Alexander, 2013). Women are also disadvantaged than men in terms of bone, muscle, and
cartilage formation, which places them at a higher risk for osteoarthritis.
However, a study by Nicolella et al. (2012) contradicts Hame and Alexander (2013)
when explaining the causes of knee osteoarthritis and how they differ between men and women.
While the study established limb alignment and quadriceps muscles as the factors influencing the
onset and progression of knee osteoarthritis, they did not find any differences between men and
women in terms of how these elements affect osteoarthritis. On the contrary, they found obesity
to be the main reason for the observed differences in the onset and progression of knee
osteoarthritis in men and women. Obesity leads to an increase in the force transmitted to the knee
joints. The force can be as high as four times the bodyweight, which makes any slight increase in
body weight cause a major increase in this force, assuming no changes in the knee joint anatomy.
Increased obesity also influences the levels of cytokines, which is a major risk factor in
osteoarthritis. The relationship between obesity and the onset of knee osteoarthritis is higher in
women than men, which might explain the higher prevalence of this MSK disorder in them
(Nicolella et al., 2012). While obesity increases the risk of osteoarthritis in both male and female
patients, this risk is higher in women than in men.
Although women have a higher prevalence of MSK diseases than men, the modes of
diagnosis and treatment do not differ among sex/gender (Hame & Alexander, 2013; O'Connor,
2006). For instance, knee osteoarthritis is diagnosed by assessing pain history, stiffness, crepitus
(abnormal popping sound in a joint), and swelling. Radiographic evaluation is also carried out to
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determine the extent of the damage. On the other hand, treatment may involve non-operative
management (i.e., activity modification and anti-inflammatory medication) or TKA surgery.
There are no differences in the diagnosis between sex/gender, although the effectiveness of the
treatment methods used has not been studied adequately (Hame & Alexander, 2013). The
diagnosis and actual treatment of osteoarthritis do not differ between men and women, which
implies that other factors cause the sex/gender disparities in its prevalence.
One possible explanation for the increased prevalence of osteoarthritis in women could
be that women and men have different psychosocial exposures (i.e., divorce, highly competitive
work situation, prolonged illness). According to the National Research Council and Institute of
Medicine (2001), workplace psychosocial exposures are known to be risk factors for MSK
symptoms. Research findings on the relationship between work-related MSK disorders and
psychosocial exposures vary, and its mechanisms are debated, but increasing evidence of this
relationship has been reported (Lundberg, 2002; Bernard et al., 1997). It is believed that
psychosocial factors affect stress responses and induce MSK pain through them, either directly
or indirectly (Baek et al., 2018). Bonger et al. (1993) argue that psychosocial factors in the
workplace induce stress symptoms, which may lead to MSK symptoms through increased
muscle tension. For example, these researchers found that psychosocial factors have a direct
effect on stress by changing individuals’ postures through stress.
Hooftman et al. (2005) observed that for both desk and assembly workers, women
reported greater job demands and less job control than men, and Josephson et al. (1999) reported
a positive association between high physical workloads and psychosocial stressors in
occupations dominated by women. Also, women have a much higher risk of exposure to
psychosocial stressors, such as gender-based discrimination and sexual harassment in their
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workplaces than men (Gutek, 2001). Thus, women’s increased exposure to workplace
psychosocial stressors may cause them to have a greater prevalence of musculoskeletal disorders
than their male counterparts.
Another potential explanation may be that women may have different responsibilities
outside of the workplace, such as a heavy domestic workload (Strazdins & Bammer, 2004).
Studies have found that women perform household-related tasks (e.g., cleaning & laundry) more
often than men, which may lead to a greater daily burden on their musculoskeletal system
(Messing et al., 2003; Treaster & Burr, 2004). In other words, women’s increased paid and
unpaid demands may lead to more stress on their MSK system, causing them to experience more
MSK symptoms than men.
Finally, the increased prevalence of MSK disorders in women may be a result of
physiological differences in the biology of their muscles, tendons, and ligaments (Punnett &
Herbert, 2000). Considering the significant adverse impact of osteoarthritis on quality of life and
health outcome measures, the disproportionate prevalence in women poses a major challenge in
the achievement of equality in health care provision (Boyan et al., 2013). In other words,
women’s increased susceptibility to MSK disorders may lead to disparities in the quality of care
they receive.
SEX/GENDER DIFFERENCES IN THE SEVERITY OF MSK CONDITIONS
In addition to a greater prevalence of osteoarthritis, women have more severe
musculoskeletal (MSK) conditions compared to men, often reporting more substantial reductions
in function and quality of life (Zhang et al., 2010). According to the United States Bone and Joint
Initiative (2014), women report having greater MSK pain than men. In 2012, 56% of adult
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women self-reported MSK pain as compared to 51% of adult men (Templeton & WatkinsCastillo, 2014).
Studies have found that women experience worse symptoms of arthritis (Blagojevic et al.,
2010; O’Connor, 2006; Petterson et al., 2007; Srikanth et al., 2005), report worse symptoms than
men with similar radiographic severity (Cho et al., 2010), and have more significant hip
degeneration (Boyer et al., 2008) compared to men. The high prevalence of osteoarthritis among
women implies that their quality of life is worse than that of men. Also, more women report that
their arthritis prevented them from performing daily activities such as feeding, dressing,
toileting, and bathing (Katz et al., 1963; Katz & Akpom, 1976).
Women have different gait patterns in response to osteoarthritis. According to Debi et al.
(2009), although there is no difference in walking speed between men and women with knee
osteoarthritis, there are significant differences in their gait cycles. Women recorded reduced
single leg support phase (SLS), which measures the time that the bodyweight is entirely
supported by one leg and enhanced double leg support phase (DLS), indicating the phase in the
gait cycle when the weight is distributed between the two feet, as compared to men. The foot
placement angles of male participants also led to a decline in the weight placed on the joints
affected by the knee. Debi et al. (2009) demonstrate that the toe out angle gait parameter may be
used as a measure of the functional severity of knee osteoarthritis in males while the SLS gait
parameter could be used for females. Thus, the differences in the strategies adopted by men and
women with knee osteoarthritis in coping with pain and pressure on joints may be attributed to
the differences in the severity of symptoms between the two sexes/genders. Surprisingly, there
were no significant pain differences between sex/gender in their study; however, the researchers
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do note that females always reported higher levels of pain compared to males and the p-values
for the pain category was close to the significant threshold (p ≤ 0.05)
McKean et al. (2007) also observed that moderate knee osteoarthritis is associated with
differences in certain gait biomechanics in females that do not exist in males. They found that
females with osteoarthritis generate less torque at the knee and ankle and less range of motion at
the knee, while males with osteoarthritis have mechanics closer to those of males without
osteoarthritis (healthy males). Also, McKean et al. (2007) measured osteoarthritis severity using
the Kellgren and Lawrence (KL) system, which is a standard method of classifying the severity
of knee osteoarthritis (Petersson, 1997). A KL classification Grade 1 demonstrates doubtful
narrowing of the joint space with possible osteophyte formation, Grade 2 shows possible
narrowing of the joint space with definite osteophyte formation, and Grade 3 indicates distinct
narrowing of joint space, moderate osteophyte formation, some sclerosis, and possible deformity
of bony ends (Kellgren & Lawrence, 1957). The researchers found that significantly more
females had a KL score of 1 (less severe osteoarthritis state), while more males had scores of 2
and 3 (more severe osteoarthritis), indicating that the women analyzed in their study were at an
earlier stage of their osteoarthritic disease. Even though the women with osteoarthritis were in an
earlier stage of their disease, they exhibited biomechanics more consistent with osteoarthritis gait
than their male counterparts. This means that females with osteoarthritis may be altering their
gait patterns either earlier in the disease process or to a greater extent than males with
osteoarthritis as a mechanism to alleviate pain, pointing to the possibility that women experience
more severe symptoms of knee osteoarthritis than men.
Interestingly, other studies have reported that the level of disease severity alone does not
explain women’s advanced adverse outcomes in osteoarthritis. According to Boyan et al. (2013),
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differences in pain between men and women may be caused by neurological factors. For
example, the serotonergic-noradrenergic pathway, a descending analgesic pathway, descends
from the brainstem to the hypothalamus and cortical structures and modulates sensory input from
the primary afferent fibers and projection neurons in the dorsal horn of the spinal cord (Millan,
2002). This neurological pathway leads to the release of serotonin, norepinephrine, and
endogenous opioids that inhibit the release of excitatory neurotransmitters such as glutamate
(Lee et al., 2011). The serotonergic-noradrenergic pathway is activated in response to a noxious
stimulus (tissue-damaging event) (Loeser & Treede, 2018). Once activated, this pathway causes
a widespread decrease in pain sensitivity. According to Lee et al. (2011), patients who have
chronic pain syndromes like osteoarthritis often have impaired or absent descending analgesic
activity. Also, Zubieta et al. (2002) found distinct differences between men and women in painrelated activation of brain mu-opioid receptors, which suggests that the interactive effects of the
opioidergic system with gonadal hormones may be an important determinant of sex-based
differences in pain sensitivity. Thus, sex/gender differences in pain sensitivity may reflect
differences in how pain is biologically transmitted within the brain.
A study conducted by Tsai (2007) found that female elders reported significantly greater
osteoarthritis pain disturbance and tended to have more depressive tendencies than males and
that these depressive symptoms were the cause for their increased osteoarthritis pain. However,
the general pain literature does not support the conclusion that depression is an explanatory
factor for osteoarthritis pain (Manninen et al., 1996). Hence, psychosocial variables may
contribute to the sex/gender differences in the severity of MSK diseases, but further research is
required.
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Women’s more severe MSK symptoms may be influenced by their unwillingness to
undergo total joint arthroplasty procedures. Demiralp et al. (2019) found social support to play a
significant role in determining whether patients undergo THA and TKA procedures. Their study
found that having a healthy spouse/partner enhances total joint arthroplasty utilization. However,
the association was only statistically significant in men and not women. This is an indication that
men may benefit from more social support from their partners/spouses than women.
Demiralp et al. (2019) also found that family dynamics also impacted women’s
willingness to undergo total joint arthroplasty procedures. Women who had children aged under
18 years were less likely to undergo surgery than those with children above this age. Elderly
women who lacked household assistance in their homes had lower odds of receiving total joint
arthroplasty when compared to those who had assistance from their children at home. On the
contrary, there was no relationship between household support from children and the odds of
having total joint arthroplasty procedures among men (Demiralp et al., 2019). These findings
indicate that familial factors influence an individual’s propensity to undergo total joint
arthroplasty procedures, but the influence varies between sex/gender. Social support factors and
family dynamics are more likely to limit women's willingness to undergo total joint arthroplasty
procedures than men, which may cause women to approach surgeons at more advanced stages of
MSK diseases than men.
The lower willingness to undergo THA and TKA procedures among women is also
evident in the options they are willing to explore. Notably, more women than men accept
continued functional decline. This phenomenon can be attributed to social relations that limit
women’s willingness to accept medical treatment. Women play the role of primary caregivers in
the family setting. Consequently, they perceive the risk of surgery and disruption to their lives
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more highly than men. Their perception of surgery risk and disruption of their role as caregivers
is so significant that they are willing to accept continued pain as an alternative (Novicoff &
Saleh, 2011). Women consider surgery to have a larger impact on their personal lives than men,
which makes them less likely to undergo it. Besides, they rarely consult their partners when they
are feeling pain because they fear that they would cause them to worry. Instead, women seek
advice from their friends, which rarely results in them seeking medical attention. Thus, the
societal roles assumed by women make them perceive surgery as highly inconvenient, making
them prefer living in pain to undergoing total joint arthroplasty procedures.
Women also feel that reporting pain may amount to wasting physicians’ time or lead to
them being called out for unhealthy behaviors such as smoking or being overweight (Judge et al.,
2010). This finding was only specific to female patients. Why might female patients feel this
way when they interact with their medical providers? Modern medicine adopted the idea that
there was a direct relationship between a noxious stimulus and the pain it caused, which is
known that the specificity theory of pain (Dusenbery, 2018). Once this idea gained traction in
American medical schools in the early twentieth century, pain that could not be explained by a
physical ailment was considered patient hysteria by healthcare providers. In other words, chronic
pain that was not a result of an observable pathology was usually assumed to be mediated by
psychological mechanisms (Dusenbery, 2018). Historian Marcia L. Meldrum writes, “Those who
suffered from unexplained chronic pain syndromes were often regarded as deluded or were
condemned as malingerers or drug abusers” (Dusenbery, 2018; pgs. 148-149). According to Dr.
Daniel Clauw, director of the Chronic Pain and Fatigue Research Center at the University of
Michigan, explained that a couple decades ago, “if you went to a doctor with chronic pain in any
particular region of the body and they couldn’t find anything wrong in that area of the body, they
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would have a tendency to then blame the patient: ‘there’s nothing wrong with you, you’re
stressed, it’s a psychiatric problem.’” They’d offer “any misattribution for those symptoms”
rather than tell them the basic truth: “that we just don’t understand pain well enough yet”
(Dusenbery, 2018; pg. 149).
Lastly, women’s lower exposure to information about total joint arthroplasty procedures
and greater fear of undergoing surgery make them less likely to opt for total joint arthroplasty
than men. Women’s lack of adequate information about total joint arthroplasty procedures
contributes to their high fear levels, which deters them from pursuing total joint arthroplasty until
their MSK diseases have progressed to advanced stages. These delays in conducting total joint
arthroplasty procedures amongst women exacerbate their MSK symptoms (Al-Taiar et al., 2013).
Volkmann & Fitzgerald (2015) found that women have less accurate perceptions about TKA
outcomes compared to men, which may lead them to have greater anxiety about undergoing
surgery compared to men (Karlson et al., 1997). To determine TKA outcome perceptions,
Volkmann & Fitzgerald (2015) asked patients to describe the outcomes that they expected for a
typical TKA patient after full recovery from surgery and compared these expectations with
observed outcomes from an external reference used in a previous study.
SEX/GENDER DIFFERENCES IN THE PROGRESSION OF MSK CONDITIONS
In addition to the severity of symptoms, Cho et al. (2010) reported a faster osteoarthritis
symptom progression in women than in men. The faster progression of osteoarthritis symptoms
in women is attributed to the sex/gender differences in cartilage volume loss. The researchers
argue that apart from women having less tibial and patella volume than men, women are more
likely to experience cartilage defects. Over time, women lose more knee cartilage volume than
men, leading to an increased progression of tibiofemoral cartilage defects (Cho et al., 2010).
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Hanna et al. (2009) also observed that women lose cartilage faster than men. This difference is
thought to be a contributor to the faster progression of knee arthritis in women (Hame &
Alexander, 2013).
However, there is conflicting evidence regarding sex/gender differences in symptom
progression in osteoarthritis. In a study to determine changes in cartilage thickness among people
with osteoarthritis, Eckstein et al. (2009) reported that sex/gender was not a significant factor
affecting symptom progression. The researchers argued that the one-year change in radiographic
knee osteoarthritis status was not significant. They indicated the possibility that one year was a
short time to report conclusively that sex/gender had no role to play, indicating the need to have
longer observational periods for conclusive reporting (Eckstein et al., 2009).
Similarly, Bastick et al. (2015) did not find any association between sex/gender and knee
osteoarthritis progression. In their study, the researchers conducted a systematic review of 43
articles to determine the prognostic factors for radiographic progression of knee osteoarthritis.
They found that baseline knee pain, Heberden nodes (bony enlargements of the last finger joint),
Varus alignment, and high levels of hyaluronic acid and tumor necrosis factor (TNF𝝰𝝰) were the
major predictors of knee progression. Varus alignment occurs when the knee is not perfectly
aligned and causes patients to develop bowlegs- a condition in which a patient’s knees stay wide
apart even when their ankles are together (Sharma et al., 2010). Hyaluronic acid is a treatment
option for patients diagnosed with knee osteoarthritis (Hermans et al., 2019). TNF𝝰𝝰 controls the
homeostasis of matrix synthesis and matrix degeneration in articular cartilage; overproduction of
TNF𝝰𝝰 causes articular cartilage matrix degeneration, which leads to knee osteoarthritis
pathogenesis (Grunke & Schulze-Koops, 2006). On the contrary, factors such as female
sex/gender, former knee injury, quadriceps strength, smoking, and physical activity were not
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associated with symptom progression (Bastick et al., 2015). While there is no consensus on the
relationship between sex/gender and osteoarthritis symptom progression, Cho et al. (2010) and
Hanna et al. (2009) indicate that women are more likely to experience faster osteoarthritis
disease progression while no studies in the literature report that males have a faster osteoarthritis
progression.
The treatment of osteoarthritis faces numerous challenges despite it being the most
common musculoskeletal (MSK) disease (Pelletier et al., 2006). In particular, the disease
develops and progresses slowly, making it very difficult to detect in its early stages. Besides,
osteoarthritis represents a heterogeneous group of disorders that affects different parts of the
body. Most importantly, the diseases lack objective and definitive biochemical markers, which
can aid therapeutic and clinical research. At times, osteoarthritis progression may take over 30
years before problems requiring treatment develop (Lane et al., 1997). Although diseasemodifying osteoarthritis drugs (DMOADs) have been developed, the process is challenging,
given the lengthy clinical trials involved, lack of consensus on the biological markets, and
multiple regulatory issues. In fact, the majority of the DMOADs that have been developed fail
safety and efficacy tests (Pelletier et al., 2006). Despite the current challenges, major strides have
been made, and the diseases can be treated using therapeutic, pharmacological, and surgical
alternatives. Even then, treatment is often lifelong (Pelletier et al., 2006). The complexity of
osteoarthritis makes it difficult to treat despite the existence of multiple treatment options being
available to patients.
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THEME 2: SEX/GENDER DIFFERENCES IN THE ACCESS TO THA AND TKA
PROCEDURES
Although women bear a larger disease burden of musculoskeletal (MSK) disease than
men, they have lower access to total joint arthroplasty treatments, particularly treatments for
osteoporosis. In the management of postmenopausal women who have had previous fractures,
physicians often adhere to clinical guidelines less than 50% of the time (Feldstein et al., 2003). A
Healthcare Effectiveness Data and Information Set (HEDIS) measure of osteoporosis
management in Medicare plans found that only 19% of women aged 67 and older who had a
previous fracture were given a bone mineral density test or prescription for a drug to prevent or
mitigate osteoporosis symptoms in the six months following the fracture in 2004 (U.S
Department of Health and Human Services, 2006). There also exists age and racial disparities
among women in accessing treatments for osteoporosis. According to Andrade et al. (2003),
older women are less likely to be administered osteoporosis treatment than younger women, even
though increased aging increases the risk of fractures. Screening and treatment rates for
osteoporosis are also lower among postmenopausal African American women than Caucasian
women (Mudano et al., 2003).
Women visit physicians for hip and knee MSK disorders more often than men (Hawkwer,
2000; Mota et al., 2012). They are also more likely to undergo total joint arthroplasty procedures
than men (Katz et al., 1996). However, the higher rate of utilization of surgical treatment options
does not consider the higher rate of prevalence of MSK disorders in women. In the U.S., 44.9 per
1000 women and 20.8 per 1000 men have a potential need for total joint arthroplasty (Hawker et
al., 2000). However, when Hawker et al. (2000) considered patients who were willing to undergo
total joint arthroplasty, the number of surgical candidates decreased to 5.3 per 1000 women and
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1.6 per 1000 men. While these data indicate high underuse of total joint arthroplasty for both
men and women, the underuse is three times higher in women than in men (O'Connor, 2006;
Novicoff & Saleh, 2011).
What could cause the greater underuse of total joint arthroplasty in women than men?
Part of the answer, it seems, is that physicians may be partially responsible for the sex/genderbased disparity in the rates of total joint arthroplasty. Borkhoff et al. (2008) used standardized
patients with identical clinical presentations of moderate knee osteoarthritis with chronic knee
pain who differed only by sex and found that the odds of an orthopedic surgeon recommending
TKA to a male patient was 22 times that for a female patient, and the odds of a family physician
recommending TKA to a male patient was two times that for a female patient. It is important to
note that no surgeon admitted awareness of gender bias in this study. Other studies have also
found that doctors and orthopedic physicians are more likely to recommend total joint
arthroplasty to male patients than female patients (Al-Taiar et al., 2013; Hame & Alexander,
2013; Novicoff & Saleh, 2011). Sex/gender bias among health care providers results in women
having lower access to total joint arthroplasty as compared to men.
There are three possible explanations for physicians’ unconscious biases when
recommending total joint arthroplasty surgery to patients. First, the physicians’ decisions to
recommend total joint arthroplasty may be based on conscious attitudes or overt discrimination
based on patients’ sex/gender. Some studies observed that physicians take women’s symptoms
less seriously and attribute their symptoms to emotional rather than physical causes (Bernstein &
Kane, 1981; Hame & Alexander, 2013) and refer women less often (Franks & Clancy, 1997)
than men for specialty care even when they have a more severe disability. Al-Taiar et al. (2013)
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also found that surgeons typically provide management treatment options rather than surgery for
female patients compared to males. (Al-Taiar et al., 2013).
A second possible explanation is that the physicians’ treatment recommendation practices
are a product of an unconscious bias based on patients’ sex/gender. Unconscious bias
materializes when a patient automatically involuntarily activates a stereotype in the physician’s
memory (Devine, 1989). These discriminatory acts coming from unconscious biases are not
deliberate, and physicians are not aware of them. Physicians are vulnerable to the same
unconscious gender biases that are pervasive in the rest of society (Ayres, 2003). Physicians may
not recommend total joint arthroplasty to female patients as frequently as males because of their
unconscious biases resulting from previous experiences, or they have heard from other
physicians that TKA is not as effective for women compared to men. This inappropriate
preconception may arise because women typically receive surgery at more advanced stages in
their diseases than men (Kats et al., 1994; Holtzman et al., 2002; Hame & Alexander, 2013) and
those with more advanced osteoarthritis have worse surgical outcomes (Holtzman et al., 2002;
Fortin et al., 1999; Petterson et al., 2007)
A third explanation is that despite identical disease symptoms, male and female patients
may differ in their presentation styles because of their sex/gender. Women generally present their
symptoms to medical providers using a narrative style, speaking more openly and personally
about their ailments, whereas men usually present their symptoms using a business-like style,
describing their illness in a more factual or reserved manner (Davis, 1988; Birdwell, 1993). This
may be because male patients possess greater knowledge about total joint arthroplasty
procedures than females (O'Connor, 2006).
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It is important to note that the restricted access to essential medical treatment among
women is not limited to only total joint arthroplasty. On the contrary, operations such as renal
transplantation and coronary artery bypass grafting are performed less frequently on women than
on men (Hame & Alexander, 2013; O'Connor, 2006). While more women undergo total joint
arthroplasty procedures than men, the rate of those who do not go through these surgeries is also
significantly higher in women than men. The higher rate in those not getting total joint
arthroplasty among women is attributed to the significantly higher prevalence of osteoarthritis in
women compared to men, which was addressed in the previous section. Overall, men are more
likely to receive a greater provision of total joint arthroplasty services relative to their needs
when compared to women (Judge et al., 2010) and women are more likely to have advanced
MSK disorders by the time they are undergoing surgery than men, which may lead to worse
surgical outcomes.
Sex/gender differences in willingness to undergo total joint arthroplasty contribute to the
failure of women to catch up with men in terms of outcomes after the surgical operation.
Although women record greater reductions in MSK pain and improved physical activity
postoperatively than men, the overall post-treatment outcomes still fall short from those reported
in men. Having more advanced MSK disease at the time of surgery and increased preoperative
pain have been blamed for contributing to worse outcomes in women than in men (Lim et al.,
2015). Since women access treatment for osteoarthritis when the disease is more advanced than
in the case of men, they present with worse MSK symptoms before the operation and worse
overall outcomes after surgery. O’Connor (2006) estimated that a one-month additional wait for
the total joint arthroplasty procedures leads to an 8% less chance of achieving a better than
expected surgical outcome.

31

THEME 3: SEX/GENDER DIFFERENCES IN THE QUALITY OF THA AND TKA
PROCEDURES
Although factors such as seeking treatment at advanced disease stages often cause worse
total outcomes for women than men, women record greater improvements in pain and physical
activity after undergoing TKA procedures (Lim et al., 2015). According to Lim et al. (2015),
both men and women record significant improvements in terms of pain and functionality after
undergoing TKA surgery. The researchers report that women record greater improvements than
men after THA for end-stage knee osteoarthritis. The increased improvement in men and women
is an indication of equal quality of THA and TKA procedures for both sexes/genders (Lim et al.,
2015). There is no difference in postoperative recovery between sex/gender in cases where
patients had the same level of pre-operative disease severity. Functional improvement after
surgery is comparable in both sexes/genders, indicating the equal quality of care offered to men
and women (Novicoff & Saleh, 2011).
Even in cases where different outcomes were reported for men and women, they were
only in the short run. For instance, Papakostidou et al. (2012) found that women recorded worse
scores in the domains of pain and physical activity than men six weeks postoperative. However,
the gains leveled out afterward. Similarly, Mehta et al. (2015) did not find any differences in the
long-term post-treatment outcomes between men and women after knee arthroplasty. For both
function and pain measures, women recorded worse outcomes than men six months after the
operation. However, there was no difference in treatment outcomes 12 months after surgery. The
differences in the treatment outcomes in the short run can be explained by differences in presurgery status between men and women.
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Before surgery, women had more disease progression than men. They recorded poorer
pain and function scores pre-surgery, which explains their worse outcomes shortly after surgery.
As the treatment takes effect, the difference between sex/gender evens out (Mehta et al., 2015).
On the other hand, Liebs et al. (2011) established that women recorded better pain, physical
function, and stiffness scores in the short-term (three- and six-months follow-ups) than men.
However, like Papakostidou et al. (2012) and Mehta et al. (2015), there was no sex/gender
difference in these outcomes at 12- and 24-month follow-ups (Liebs et al., 2011). Although
women may report worse outcomes than men after surgery, this difference is not sustained in the
long run.
The failure rate of THA and TKA procedures is not highly dependent on sex/gender.
According to the National Institutes of Health (2003), the influence of sex/gender on revision
rates varies from study to study and does not appear to be influenced by sex/gender significantly.
For instance, it is reported that two large Canadian and Swedish studies found sex/gender to play
no role in influencing the revision rate following THA and TKA procedures. However,
American men have been shown to have a greater risk of revision than women. Men also have a
higher risk of failure than women. Factors other than sex/gender, such as the surgeon’s
experience and choice of prosthesis, may have an impact in determining the outcome of surgery
(National Institutes of Health, 2003). Thus, the success rate of arthroplasty is not influenced by
sex/gender.
Another way of assessing the sex/gender differences in the quality of THA and TKA
procedures is assessing the influence of sex/gender on patient satisfaction. Delanois et al. (2018)
set out to determine how sex/gender influenced patients’ ratings of their experiences after
receiving THA procedures. The major factors that determined hospital ratings differed between
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men and women. While men were mainly influenced by pain management, women focus more
on staff responsiveness. Both men and women considered communication with nurses and
doctors an important factor while rating their experience. Despite the differences in factors that
exert more influence on patient experience ratings between sex/gender, the overall hospital rating
did not differ significantly (Delanois et al., 2018). A review by Okafor & Chen (2019) found
mixed results regarding the influence of sex/gender on satisfaction with THA procedures. Many
of the studies did not find major differences in the degree of satisfaction between sex/gender
(Okafor & Chen, 2019). Although Rolfson et al. (2009) established higher satisfaction in men
than women following hip arthroplasty, treatment outcomes were similar. The difference in
satisfaction did not reflect the similarity in pain reduction between men and women (Rolfson et
al., 2009). Thus, there is no significant difference in the satisfaction with total joint arthroplasty
between men and women.
Although there is no major difference in the quality of the total joint arthroplasty
procedure between sex/gender, the low access of care amongst women implies that the quality of
care they receive for knee and hip osteoarthritis is worse than that of men. Although conservative
measures — use of pain medication, disease-modifying drugs, and therapy — are the most
preferred approaches to treating osteoarthritis, they are only effective in the early-stage and for
mild osteoarthritis. On the other hand, patients with severe osteoarthritis, especially in the
presence of severe pain and deformity, or in cases where conservative measures have failed, are
recommended to undergo total joint arthroplasty (Wood et al., 2013). According to Papakostidou
et al. (2012), total joint arthroplasty is the most effective treatment option among patients with
medication-unresponsive osteoarthritis. This effectiveness is evident in pain reduction, deformity
correction, and improvement of patients’ quality of life. Low access to THA and TKA
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procedures amongst women when compared to men implies that the care that they receive,
especially when their osteoarthritis is not responding to conservative treatment approaches, is not
of the highest quality.
THEME 4: SEX/GENDER DIFFERENCES IN THE COST OF THA AND TKA
PROCEDURES
Osteoarthritis is a musculoskeletal (MSK) disorder affecting a large proportion of the
population. It is a leading cause of long-term disability, which implies high direct and indirect
costs. The financial burden of osteoarthritis leads to direct costs in the healthcare system and
indirect costs to societies. Given the disparities in the rate of osteoarthritis between men and
women, the latter contribute more to the cost burden. Women report more severe knee and hip
osteoarthritis, osteoarthritis-related disability, and difficulties in performing daily tasks than men.
Although both men and women underutilize arthroplasty, the underuse in women imposes a
larger financial burden on the government, insurance companies, individuals, and society than
underuse in men (Hawker et al., 2000). Arthroplasty increases work productivity, especially
among working-age patients, thus presenting an economic benefit. The societal benefits attained
offset the direct surgery costs incurred.
Osteoarthritis is very expensive, considering the long periods of treatment. Losina et al.
(2015) estimated that the lifetime direct medical costs for persons diagnosed with knee
osteoarthritis were $129,600. Many patients wait for an average of 13 years before they seek
TKA procedures, opting to try out non-surgical regimens before embarking on the surgical
option. Despite the long waits before a TKA procedure, most of the patients underwent surgery
before the age of 65. At this time, most health care costs are incurred by private insurers.
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However, patients are likely to have multiple revision surgeries after the age of 65, during which
time the costs are incurred by social insurance such as Medicare (Losina et al., 2015). While
reporting on the annual costs of treatment of knee and hip osteoarthritis, Gupta et al. (2005)
estimated direct costs of $12,200 per annum. Patients with osteoarthritis-related costs attributed
to 81% of the total economic burden to indirect costs. Direct costs included the purchase of
assistive devices and pain help, while indirect costs included formal and informal lost labor and
caregiver time losses (Gupta et al., 2005). Despite the differences in the categorization of costs
and different measurement methods in the two studies, indirect costs account for the major
economic cost of osteoarthritis.
Women are unfairly affected by the costs associated with osteoarthritis. Gupta et al.
(2005) found that women are more likely to report costs associated with osteoarthritis than men.
The costs reported were influenced by the state of health and osteoarthritis severity.
Consequently, the high likelihood of women to report costs might be as a result of having
advanced cases of osteoarthritis and poor health conditions. This is supported by the finding that
women, especially in rural areas, reported higher direct costs when compared to men (Gupta et
al., 2005). In the study by Ackerman, Livingston & Osborne (2016), women participants
reported that they did not undergo THA and TKA procedures due to cost barriers, especially of
post-surgical care. In the study, male participants also cited access to private insurance as a
major factor influencing access to THA and TKA procedures (Ackerman, Livingston, &
Osborne, 2016). In countries such as the U.S., insurance acts as a major determinant of access to
health services such as arthroplasty. Lack of insurance presents a major barrier to the U.S.
healthcare system. Women are more likely to experience barriers related to health insurance
when seeking THA and TKA procedures than men (Hawker et al., 2000). Therefore, women face
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cost barriers in THA and TKA procedures because the odds of having these procedures are
influenced by health insurance. Medicaid coverage increases the odds of having total joint
arthroplasty procedures among people with osteoarthritis. On the other hand, the lack of health
insurance reduces the utilization of total joint arthroplasty procedures (Demiralp et al., 2019).
The lower social support received by women seeking total joint arthroplasty procedures
when compared to men imposes extra costs of this treatment, which makes it difficult for women
to access health services. Total joint arthroplasty surgery leads to reduced mobility, which leads
to additional pecuniary and nonpecuniary costs. Having total joint arthroplasty surgery presents
an economic decision, which is dependent on the economic cost involved. On the one hand,
forgoing a total joint arthroplasty procedure implies that one must live with pain and a certain
level of physical dysfunction. These effects often have economic costs related to productivity.
On the other hand, having surgery is an investment that requires direct costs of surgery.
When one does not have adequate social support, they may be required to make alternative
caregiving arrangements to help them cope after surgery. Such arrangements cost money and
increase the cost of surgery. Women have lower social support than men. Consequently, their
cost of undergoing total joint arthroplasty procedures is higher because they not only have to pay
the direct cost of surgery but must hire caregiving services to carry out household roles during
recovery from surgery (Demiralp et al., 2019). With this understanding of the costs of surgery,
women incur higher costs to undergo total joint arthroplasty procedures even if the direct costs of
operation are standard for both sexes/genders.
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THEME 5: HEALTH POLICY
A multitude of factors has contributed to sex/gender inequalities in health care. These
factors range from biological, access to and control over resources, and sex/gender-related family
and societal dynamics. The negligence of sex/gender often contributes to the sex/gender-based
inequities during the planning and implementation of health strategies and policies. Although
there are multiple policy efforts aimed at promoting sex/gender equity in health, they often lack a
multisectoral approach. Health policies focus primarily on the medical aspects of health care
while ignoring other domains. However, such policies have limited effectiveness because they
fail to consider factors such as power dynamics in the family setting that prevent women from
accessing services in the same way as men. To address these gaps, a multisectoral approach to
health policy promotion should be adopted. Health policies should address the social and
environmental determinants of sex/gender-based health inequities. The social and economic
change should also be pursued as a means of addressing sex/gender-based health disparities
(Östlin et al., 2006).
The high disease burden and inequalities evidenced in the THA and TKA procedures
have necessitated health policy recommendations to address the issue. Researchers have
provided several strategies to address the sex/gender gap in the epidemiology, access, quality,
and cost of THA and TKA procedures. Nakua et al. (2015) argue that sex/gender differences
necessitate the implementation of sex/gender-based policies in national health policies to address
the gap. Appropriate geriatric care policies that consider the existing sex/gender differences
should be implemented to address the expected rise in demand as the life expectancy of people
increases. The increase in life expectancy is likely to increase the demand for THA and TKA

38

procedures among the elderly (Nakua et al., 2015). However, the researchers do not offer any
specific policy that can be used to address this issue.
To address the sex/gender differences in the cost of THA and TKA procedures, Losina
et al. (2015) recommend the expansion of the eligibility criteria for TKA under Medicare
coverage. Considering that many patients with osteoarthritis undergo TKA before the age of 65,
the treatment is not eligible for Medicare coverage. Expanding eligibility criteria to include
younger ages can increase patients’ access to THA and TKA procedures by shifting the cost to
the government. As the cost burden is shifted to the government, people would change the TKA
timing. However, implementing such a policy would necessitate a serious consideration of the
potential effects of shifting costs to Medicare (Losina et al., 2015).
LITERATURE REVIEW CONCLUSION
This section set out to assess sex/gender differences in THA and TKA procedures by
reviewing the existing literature. The review established major sex/gender-based differences in
the epidemiology of hip and knee osteoarthritis in terms of incidence, manifestation, and risk
factors. However, there was no difference in the diagnosis and the actual treatment approach
between men and women. Differences were also noted in access to THA and TKA procedures,
with women having lower access than men in terms of rate of utilization, medical practitioner
bias, and access to information. Another sex/gender disparity that was noted in the literature was
related to the cost of surgery. Although the direct costs of osteoarthritis did not differ
significantly between men and women, the latter incurred higher indirect costs. However, there
were no notable sex/gender differences in the quality of THA and TKA procedures. There is a
limited focus on health policy targeting the reduction of sex/gender disparities in the treatment of
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knee and hip osteoarthritis. Future work should focus on specific policies that can be utilized to
address this sex/gender-based health disparity.
SENIOR THESIS RESEARCH STUDY AND QUESTION
My senior thesis provides an original study that analyzes 1) whether there are any
sex/gender-specific differences between male and female patients undergoing THA and TKA
and 2) whether a physician-led Accountable Care Organization (ACO) participating in the
Medicare Shared Savings Program (MSSP) in the western U.S. is successful at lowering the total
cost of care for its patients between the years 2016 and 2018. I chose to analyze THA and TKA
procedures for my senior thesis project for two reasons. One, there has been significant health
reform targeting THA and TKA procedures. A recent payment model, Comprehensive Care for

Joint Replacement (CJR), implemented in 2016, focuses on improving the quality of patient care
and decreasing health costs for Medicare beneficiaries undergoing THA and TKA procedures by
paying a “target price” for all related care and services within a 90-day episode of care, including
the post-discharge period (McLawhorn et al., 2017). Two, THA and TKA procedures are among
the most frequently performed operating room procedures performed in the U.S. (Fingar et al.,
2016). The use of THA procedures is projected to grow 71% by 2030, and TKA procedures are
projected to grow 85% by 2030 (Sloan et al., 2018).
Because MSSP ACOs are a relatively new topic in healthcare, and it is difficult to collect
longitudinal cost data, there has been a lack of scholarly research on whether MSSP ACOs are
true health cost containers. This study is important and relevant because it is the first of its kind
to analyze both the sex/gender differences in postoperative outcomes between male and female
patients undergoing THA and TKA procedures and whether an MSSP ACO is reducing the costs
of care for its beneficiaries. The following section will briefly explain what MSSP ACOs are,
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why they were created, and how they are reimbursed for the services they provide to their
beneficiaries.
THE ABCS OF ACOS: ACCOUNTABLE CARE ORGANIZATIONS EXPLAINED
WHAT IS AN ACCOUNTABLE CARE ORGANIZATION?
Accountable Care Organizations (ACO) were created by Section 2706 of the Patient
Protection and Affordable Care Act (ACA) to address rising health costs, uneven quality of care,
and fragmented care that has plagued the U.S. healthcare system (Fisher et al., 2011). ACOs aim
to improve their beneficiaries’ experiences of care, improve their beneficiaries’ health, and their
per capita costs of health care, a conceptual framework called the Triple Aim (Institute for
Healthcare Improvement, 2020) (Appendix 2). An ACO is a network of health care providers
and hospitals that shares financial risk and medical responsibility for providing team-based,
coordinated care to Medicare patients. Health care providers in this network may include
physicians, surgeons, pharmacists, nurses, health care assistants, caregivers, lab specialists,
psychiatrists, mental health professionals, rehabilitation workers, and other health care
specialties. This group of people collaboratively work together to coordinate patient care to
obtain maximum care for clients and the group “accepts joint responsibility for health care
spending and quality for a defined population of patients” (Song, 2014, pg. 2).
According to Song (2014), the three key characteristics of the ACO are: “joint
accountability, accountability for both quality of care and health care spending, and
responsibility for the care of a population of people. Joint accountability means that health care
providers across specialties, disciplines, and care settings are incentivized to deliver patient care
together and coordinate care more effectively. ACO incentives for health care providers are
agreed upon at the organizational level in an ACO contract. Together, health care providers and
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hospitals take on the financial risks and rewards outlined in the ACO contract. Incentives such as
shared cost savings and quality bonuses are based on how the overall organization performs,
rather than on the performance of an individual health care provider, practice, or hospital.
Under Medicare’s fee-for-service (FFS) payment system, doctors and hospitals are
reimbursed for each test and procedure provided for their patients. Doctors and hospitals within
ACOs still operate under an FFS system but are incentivized to be more efficient by receiving
financial bonuses when they keep the costs of healthcare down. Under ACOs, doctors and
hospitals must meet specific quality benchmarks, focusing on disease prevention and carefully
managing patients with chronic diseases and multiple comorbid conditions (Burke, 2011).
If the ACO cannot save money, it may be responsible for the investments made to
improve its care, such as adding new nurse care managers. An ACO may also have to pay a
penalty if it does not meet its performance and savings benchmarks. However, ACOs under the
management of physicians or rural providers can apply to receive payments in advance to assist
them in building the necessary infrastructure to be able to provide coordinated care – an
exception the Obama administration enacted after rural hospitals complained (Blackstone, 2016).
At the center of each patient’s care is a primary care physician. For purposes of the
Medicare Shared Savings Program (MSSP), a primary care physician is defined as a physician
who has primary specialty designation of internal medicine, general practice, family practice, or
geriatric medicine, or for services provided in federally qualified health clinics (FQHCs) or rural
health clinics (RHC) (American Academy of Family Physicians, 2011). In theory, having
primary care physicians act as the centerpiece of health care delivery ensures that patients are
receiving the right care at the right time while avoiding unnecessary duplication of medical
services and preventing medical errors. When an ACO achieves in delivering high-quality care
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and spending health care dollars more wisely, it shares in the cost savings it achieves with the
Medicare program. According to the provisions outlined in the ACA or sometimes referred to as
Obamacare, each ACO must manage the health care needs of a minimum of 5,000 Medicare
beneficiaries for at least three years (Gold, 2015). This minimum requirement was enacted to
ensure that there was a large enough sample size in the ACO and an adequate amount of time for
the ACO to report meaningful performance measurements to the government (Merlis, 2010).
HMO VS. ACO COMPARISON
Even though Accountable Care Organizations and Health Maintenance Organizations
(HMOs), a type of Managed Care Organization (MCO), share many characteristics such as
managing risk, building physician networks, and promoting the health of its members and
targeting resource utilization (Tabriz et al., 2017), ACOs are different than HMOs. There are
three important differences between them, which will be outlined below. This information can
also be found in Figure 7, which outlines the differences between ACOs and HMOs.
First, patients enrolled in an ACO are not locked into an integrated network. ACO
patients can access health care providers and settings within or outside of the ACO integrated
network; thus, patients can choose any primary care physician, specialist, or hospital they want.
HMO patients must choose health care providers and hospitals within the network for a certain
minimum period. Also, patients enrolled in an HMO must stay within the network, but doctors
do not. If a patient’s doctor drops out of the network, HMO enrollees cannot see them, which
hinders continuity of care. ACOs do not have enrollment lock-in provisions; therefore, patients
can seek care freely.
Second, ACOs are not insurance companies; ACOs are provider-led organizations
consisting of physicians, hospitals, and other health care providers. Therefore, ACOs do not have
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utilization reviews and no pre-approval process. In the HMO model, insurance companies place
primary care physicians as “gatekeepers” to control costs and patient care. In this model, primary
care physicians are tasked to oversee pre-authorizations and referrals, which controls patients’
access to specialists, tests, and hospitalizations. Insurance companies tell primary care physicians
what is and is not permitted, limiting benefits and patients’ choices of hospitals or specialists.
Because ACOs are provider-led, primary care physicians coordinate care through a team
approach with patients and other health care providers to create a value-based health care
delivery system. Value-based healthcare is a care delivery model in which providers, including
hospitals and physicians, are reimbursed based on patient health outcomes (Catalyst, 2017). In a
value-based environment, the focus is toward quality, shared risk, and population health
management (Health Research & Educational Trust, 2014). ACOs allow providers to utilize the
best medical practices and provide health care providers the autonomy to choose the most
appropriate path to efficient, high-quality care.
Lastly, ACOs have financial incentives and reimbursement structures centered around
quality performance and shared risk. Also, HMOs are full capitation models, placing all financial
risk on the providers, who are paid a fixed amount per patient, regardless of whether patients
seek care, and regardless of how much care patients may need. If patient care exceeds the payper-patient allocated, the providers lose money, not the insurers. This capitation incentivizes
managed care, but not quality care. Because of this, critics of HMOs are concerned that HMO
physicians may be financially influenced to withhold care from patients. ACOs offer a variety of
payment models, such as a modified FFS system, and most ACOS are built on sharing financial
risk between providers and insurers. In ACOs, providers are incentivized with shared savings
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and bonuses when they successfully meet the required performance focused on increased quality
and lower cost of care.

Figure 7. ACOs vs. HMOs Comparison (Tabriz et al., 2017)
MEDICARE SHARED SAVINGS PROGRAM (MSSP)
The Medicare Shared Savings Program (MSSP) is Medicare’s flagship ACO program
(Centers for Medicare and Medicaid Services, 2019c). A flagship program is a major program of
the government to achieve a certain goal; in this case, decrease health care costs and increase the
quality of patient care. MSSP is Medicare’s largest ACO program (Muhlestein et al., 2017). An
ACO that joins the MSSP can have two “agreement” periods” (each period lasts three years) in
track 1 (upside risk only) before moving into tracks 2 or 3 (upside and downside risk). One-sided
risk models only have upside risk, which means providers share in savings if spending is below
the benchmark but do not have to reimburse payers if payment exceeds the benchmark. Thus,
track 1 in the MSSP is a one-sided risk model, while track 2 is a two-sided risk model. Two-
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sided risk models have upside and downside risk, which means providers still share in the
savings but are also responsible for some of the loss if spending is above the benchmark. It is
important to note that the term “MSSP ACO'' refers to ACOs that are participating in the MSSP.
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CHAPTER 2: METHODS
DATA SOURCE AND STUDY POPULATION
As previously mentioned, the present research aims to analyze whether there are
sex/gender-specific differences between male and female patients undergoing total hip
arthroplasty (THA) and total knee arthroplasty (TKA) procedures. This study analyzes
longitudinal cost data from the years 2016 and 2018 to determine the efficacy of a physician-led
MSSP ACO in the western U.S. Among all patients seeking care in this MSSP ACO, between
the years 2016 and 2018, patients meeting specific criteria were sampled to analyze whether
there were sex/gender differences between male and female patients undergoing THA and TKA
procedures.
It is important to note that the data provided by the MSSP ACO were anonymous. The
data did not contain any patient identifiers such as name and address, or even the provider’s
name. Also, the Chief Executive Officer (CEO) of this physician-led MSSP ACO had permitted
me to use their data for my senior thesis project. Lastly, I received approval from the Union
College Human Subjects Review Committee to use the MSSP ACO’s data in my research.
Patients were selected for the study based on having one or multiple of the following
Diagnosis Related Group (DRG) codes:
Code 468: “Revision of Hip or Knee Replacement without Complication or
Comorbidity”
Code 469: “Major Hip and Knee Joint Replacement or Reattachment of Lower
Extremity with Major Complication or Comorbidity (MCC) or Total Ankle
Replacement”
Code 470: “Major Hip and Knee Joint Replacement or Reattachment of Lower
Extremity without MCC”
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These DRG codes indicate the type of procedures the patients within the MSSP ACO had
undergone. DRG Codes 468, 469, and 470 represent THA and TKA procedures. The MSSP
ACO provided data on the average total cost of care per patient/beneficiary, CMS Risk-Adjusted
Factor (RAF) scores, and PHDS (Predicted Hyperglycemic Crisis Death) scores for male and
female patients undergoing THA and TKA procedures. To get reimbursed for the services it
provides, this organization collects these data and forwards them to the Centers for Medicare and
Medicaid Services (CMS).
CMS uses RAF scores to differentiate payments based on the complexity of patient
diagnosis. In theory, the higher the RAF score, the sicker the patient is and therefore requires a
greater amount of care from health care providers. RAF scores generally range between 0.9 and
1.7 (Yeatts & Sangvai, 2016). CMS RAF scores are normalized to a value of 1.0. Patients with
RAF scores less than 1.0 are considered relatively healthy, and patients with RAF scores greater
than 1.0 are unhealthy compared to the general population (Yeatts & Sangvai, 2016). CMS RAF
scores justify higher payments to health care providers. In other words, these risk scores are used
to adjust payments back to the MSSP ACO. CMS RAF scores are reset at the beginning of every
calendar year, requiring health care providers to reassess patients’ diagnoses and chronic
conditions every year.
The data, as presented by the MSSP ACO, did not lend itself to statistical analyses.
Specifically, I could not calculate if there was a statistically significant difference between male
patients’ PHDS risk scores and female patients’ PHDS risk scores. Also, I could not determine if
there was a statistically significant difference between male patients’ average total cost of care
and female patients’ average total cost of care. To ensure anonymity, the MSSP ACO did not
provide me with data that showed their beneficiaries’ sex/gender. The MSSP ACO only provided
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me with data that contained the average PHDS risk score for both male and female patients
undergoing procedures THA and TKA procedures and the total cost of care for these male and
female patients over the 2016 to 2018 time period. To conduct statistics on the data, I would
need the PHDS risk score and the total cost of care for each patient in the MSSP ACO who
underwent THA and TKA procedures; these data would need to be divided by the patients’
sex/gender to compare the PHDS risk scores and the total costs of care between male and female
patients. Thus, p-values could not be calculated to see if there were statistically significant
differences between men and women undergoing THA and TKA procedures.
PHDS Risk Stratification Algorithm
To compare the differences in the Predicting Hyperglycemic Crisis Death (PHDS) risk
score between male and female patients undergoing THA and TKA procedures, I compared the
mean scores for both sexes/genders. As seen in Table 1, a risk stratification score based on a
proprietary algorithm used by the MSSP ACO was used to stratify patients’ complexities based
on their diagnoses, hospital admissions, length of stay in days, readmissions, emergency
department (ED) visits, age, drug or alcohol abuse, and behavioral health. The risk stratification
algorithm allowed me to analyze whether there were sex/gender differences between male
patients and female patients’ outcomes after receiving THA and TKA procedures.
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Table 1. PHDS Risk Stratification Variables
ID

Parameter

Comments

Conditional Logic

1

Diagnoses

Within the past 12 months

Inclusionary weighted
(Coding list)

2

Hospital
Admissions

Only for inpatient stays in the last 12 months by Thru date.

Within the past 12
months

3

Length of Stay
(days)

Only for inpatient stays in the last 12 months by Thru date.

Weighted per ID2

4

Readmissions

Only for inpatient stays in the last 12 months by Thru date.

Within <=30 days of
ID2

5

ED Visits

Only for ED visits in the last 12 months by Thru date.

Within the past 12
months

6

Age

7

Drug or Alcohol
Abuse

DX Class = (Alcohol-Related Disorders OR SubstanceRelated Disorders) AND Chronic

DX Coding - Within the
past 12 months

8

Behavioral
Health

DX Body System = (Mental Health) AND DX Class = (NOT
Substance-Related) AND (NOT Alcohol Related) AND (NOT
Delirium Dementia …Disorders)

DX Coding Psych
(12 months)
Hospitalizations (12
months)

Weighted

*PHDS, Predicting Hyperglycemic Crisis Death. ED, Emergency Department. Inpatient is defined as patients who stay overnight
in the hospital. DX is the abbreviation for diagnosis, the determination of the nature of a disease.

A key advantage of using the Predicting Hyperglycemic Crisis Death (PHDS) Risk Stratification
Score over CMS’s RAF score is that it does not reset every calendar year. The continuity in the
PHDS risk stratification score allowed me to compare data over three years (2016-2018). The
PDHS risk stratification score accounts for patients’ undergoing the above-noted procedures and
subsequent care, which may not correspond to the CMS payment calendar.
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CHAPTER 3: RESULTS
Between the years 2016 and 2018, 447 patients (156 males and 291 females) met the
criteria for inclusion in this study. The criteria for the present study was that patients had to be
part of this physician-led MSSP ACO and had to undergo total hip arthroplasty (THA) and total
knee arthroplasty (TKA) surgical procedures. Table 2 describes the patient sample population
who received THA and TKA procedures within the MSSP ACO between the years 2016 and
2018.
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Table 2. Demographic Characteristics of the Patient Population, 2016 to 2018.
Year

2016

2017

2018

Total

Non-Hispanic White

122 (81.9%)

124 (83.2%)

119 (79.9%)

365 (81.7%)

Black

12 (8.05%)

8 (5.37%)

14 (9.40%)

34 (7.61%)

Hispanic

7 (4.70%)

7 (4.70%)

4 (2.68%)

18 (4.03%)

Asian

5 (3.36%)

6 (4.0%)

4 (2.68%)

15 (3.36%)

Other

3 (2.01%)

3 (2.01%)

3 (2.01%)

9 (2.01%)

Unknown

0 (0.00%)

1 (0.67%)

5 (3.36%)

6 (1.34%)

Male

55 (36.9%)

52 (34.9%)

49 (32.9%)

156 (34.9%)

Female

94 (63.1%)

97 (65.1%)

100 (67.1%)

291 (65.1%)

Medicare Only

126 (84.6%)

130 (87.2%)

136 (91.3%)

392 (81.7%)

Medicare and Medicaid

21 (14.1%)

19 (12.8%)

11 (7.38%)

51 (11.4%)

Other

2 (1.34%)

0 (0.00%)

2 (1.34%)

4 (0.89%)

Total

149

149

149

447

Number of Patients by Race

Number of Patients by Sex/Gender

Number of Patients by Insurance Status

*“Other” represents patients who had another dual-eligible insurance that was not Medicare and full Medicaid
coverage. Dual-eligible patients are defined as those with both Medicare and Medicaid insurance.

Out of the 447 patients within the MSSP ACO who underwent THA and TKA procedures
between the years 2016 and 2018, 81.7% were non-Hispanic White (n=365), and the next largest
category, 7.61%, were Black (n=34). Sixty-five percent of the patients in the physician-led
MSSP ACO who underwent THA and TKA procedures between the years 2016 and 2018 were
women (n=291), while 35% were men (n=156). Most patients in the MSSP ACO who underwent
THA and TKA procedures had Medicare insurance only (n=392; 81.7%), but most of the
remaining patients had both Medicare and Medicaid insurances (n=51; 11.4%).
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Table 3 describes the two different risk stratification scores, categorized by the patient’s
sex/gender, that were used to establish post-surgical outcomes for the patient population who
underwent THA and TKA procedures within the MSSP ACO. CMS calculated one of the risk
scores, and the other risk score was calculated using the MSSP ACO’s proprietary risk
stratification algorithm (PHDS), which was described in the “Methods” section.

Table 3. Risk Scores Stratified by Sex/Gender, 2016 to 2018.
Year

2016

2017

2018

Average

Male

18.9

16.8

17.4

17.7

Female

16.1

14.2

16.9

15.7

Average Patient

17.1

15.1

17.1

16.4

Male

1.4

1.1

1.1

N/A

Female

1.4

0.9

1.0

N/A

Average Patient

1.4

1.0

1.0

N/A

PHDS Risk Score

CMS RAF Score

*RAF, Risk-Adjusted Factor. PHDS, Predicting Hyperglycemic Crisis Death. CMS, Centers for Medicare, and Medicaid Services.
The Average Patient PHDS Score represents the average PHDS risk score for all the patients undergoing THA and TKA procedures.
N/A indicates that the average risk score was not calculated. CMS RAF scores were not averaged because they are reset annually.

Higher CMS RAF scores and PHDS scores indicate that a patient has more complex medical
conditions and greater comorbid conditions (i.e., diagnoses, hospital admission, length of stay in
days, readmission, ED visits, age, drug, or alcohol abuse, behavioral health). These risk scores
are used to adjust the MSSP ACO’s health service reimbursement that correlates with a higher
level of complexity of care.
As seen in Table 3, there are considerable deviations from the CMS RAF scores and the
PHDS risk scores, which is due to the CMS RAF score resetting at the end of every calendar
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year. We also see that male patients had a greater PHDS risk stratification score than female
patients in 2016, 2017, and 2018. Thus, men had a greater average PHDS risk score over the
three years than women (17.7 vs. 15.7). Men had a greater average PHDS risk stratification score
than the average patient undergoing THA and TKA procedures in the MSSP ACO (17.7 vs.16.4)
(Table 3).
Concerning patients’ total costs of care data shown in Table 4, we see that male patients
undergoing THA and TKA procedures in the MSSP ACO had a lower average total cost of care
than female patients in 2016 and 2017; however, we see that female patients’ average total cost
of care was lower than those of male patients in 2018.
Table 4. Total Cost of Care for Each Patient Categorized by Sex/Gender, 2016 to 2018.
Year

2016

2017

2018

PBPY ($)
Male

$17,624

$17,398 $16,626

Female

$18,440

$18,037 $15,051

Average Patient $18,139

$17,814 $15,569

*PBPY, Per Beneficiary Per Year.

Figure 8 represents a graphical visualization of the average total cost of care data described in
Table 4.
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Figure 8. Decreasing Cost to Treat Patients Stratified by Sex/Gender, 2016 to 2018.

The data in Figure 8 show an interesting trend between the years 2016 and 2018. We see that the
total costs of care for men, women, and the average patient undergoing THA and TKA
procedures in the physician-led MSSP ACO are decreasing over the three years. Specifically,
male patients’ average total cost of care decreased by 5.66%, female patients’ average total cost
of care decreased by 18.4%, and the costs associated with treating the average patient in the
MSSP ACO who underwent THA and TKA procedures decreased by 14.2% between the years
2016 and 2018.
Table 5 compares the average total cost of care to treat patients with only Medicare
insurance undergoing THA and TKA procedures with the average total cost of care to treat dualeligible patients who received the same orthopedic procedures in the MSSP ACO. As seen in
Table 5, the average total cost of care for patients with only Medicare was less than the average
total cost of care for dual-eligible patients in all three years (i.e., 2016 - 2018).
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Table 5. Total Cost of Care Per Patient Stratified by Insurance Status, 2016 to 2018.
Year

2016

2017

2018

Insurance Type
Medicare Only

$17,607 $17,503 $15,587

Medicare and Medicaid

$19,890 $19,944 $15,777

*Dual-eligible patients are defined as those with both Medicare
and Medicaid insurance.

Figure 9 represents a graphical visualization of the average total cost of care to treat Medicareonly patients and dual-eligible patients described in Table 5.

Figure 9. Decreasing Cost to Treat Patients Stratified by Insurance Status, 2016 to 2018.

The same trend mentioned in Figure 8 is seen in Figure 9. We see that the average total costs of
care for patients with only Medicare insurance and dual-eligible patients who received THA and
TKA procedures in the MSSP ACO are decreasing between the years 2016 and 2018. Over these
three years, Medicare-only patients’ average total cost of care decreased by 11.47%, and dual-
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eligible patients’ average total cost of care decreased by 20.7%. Figure 9 also shows that the total
cost of care for Medicare-only patients and dual-eligible patients remains stagnant between 2016
and 2017 but drops significantly in 2018. This cost-trend between 2016 and 2018 could be an
indicator of 1) the MSSP’s maturation as CMS has refined its performance measures and the
program’s technical components, and 2) MSSP ACOs are learning how to succeed under these
arrangements and are consequently developing better healthcare delivery practices. However, the
data from the present study cannot explain why this trend occurred within the three years; thus, I
can only speculate why this trend occurred. Interestingly, CMS data on total earned shared
savings from all MSSP ACOs in the U.S. indicate a trend like the one seen in Figure 9. The total
earned shared savings from all MSSP ACOs were $700 million in 2016, rose to $799 million in
2017, and jumped to $983 million in 2018 (Centers for Medicare and Medicaid Services, 2020).
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CHAPTER 4: DISCUSSION
The purpose of this study was to determine whether there were any sex/gender-specific
differences in postoperative outcomes between male and female patients who underwent total hip
arthroplasty (THA) and total knee arthroplasty (TKA) procedures in a physician-led Accountable
Care Organization (ACO) participating in the Medicare Shared Savings Program (MSSP) located
in the western U.S. over three years (2016 to 2018).
The present study only analyzed patients who received procedures coded with DRG
codes 468, 469, and 470, which represent THA and TKA procedures. To clarify, this study did
not analyze all the patients within the physician-led MSSP ACO, but only looked at patients
within the MSSP ACO who underwent THA and TKA procedures. Thus, this study cannot form
any conclusions about all the patients within this MSSP ACO, but it can form conclusions about
the sub-sample of patients (n=447) who underwent THA and TKA procedures.
SAMPLE POPULATION DEMOGRAPHICS
Patients undergoing THA and TKA procedures in the MSSP ACO between the years
2016 and 2018 were segmented into categories based on their race/ethnicity, sex/gender, and
insurance status. Dividing the demographic data into multiple categories provided a more indepth analysis of the composition of these patients.
According to my findings, the demographic data of the sample patient population indicate
that most of the MSSP ACO patients who underwent THA and TKA procedures were nonHispanic White (81.7%) and had only Medicare insurance (81.7%). Singh et al. (2014) found
that the standardized utilization rates for both primary and revision THA and TKA procedures
were significantly lower for Blacks than non-Hispanic Whites, as well as Epstein et al. (2014),

58

who observed that MSSP ACO patients are less likely to be Black or eligible for Medicaid and
had higher incomes than non-ACO patients. It is important to note that the findings from this
study cannot be generalized to all patients within an MSSP ACO or all patients undergoing THA
and TKA procedures. This study only examined patients who underwent THA and TKA
procedures within an MSSP ACO. CMS data on the MSSP show that 82% of all MSSP ACO
beneficiaries in the U.S. have only Medicare insurance, which is like the population of Medicareonly patients who underwent THA and TKA procedures in this MSSP ACO (Centers for
Medicare and Medicaid Services, 2020). However, the CMS data also indicate that 17% (11%disabled; 6%-aged dual) of all MSSP ACO beneficiaries are dual-eligible patients, which is
slightly greater than the population of dual-eligible patients who underwent these two procedures
in this MSSP ACO. It is important to note that the study’s findings cannot be generalized to all
MSSP ACOs because this study only examined patients who underwent THA and TKA
procedures within one MSSP ACO.
Patients’ race and sex/gender did not reflect the population demographics of the area
where this physician-led MSSP ACO is located. Patients who underwent THA and TKA
procedures and were part of this MSSP ACO were more likely to be non-Hispanic White and
less likely to be Hispanic and Asian than the geographical area where it is located. However, the
number of patients who were Black is similar to the MSSP ACO’s geographical area. The
patients in this MSSP ACO may explain the differences between the demographics of the
patients who underwent THA and TKA procedures in this sample and the population
demographics. The MSSP ACO patient study population may not be representative of the
general population; however, I do not have data on the entire set of patients in this MSSP ACO.
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In short, this MSSP ACO could be attracting patients with a certain income, sex/gender, and race
(Epstein et al., 2014).
My findings also indicate that patients who underwent THA and TKA procedures in the
MSSP ACO were predominantly female (Table 2). A study conducted by Epstein et al. (2014)
reported that more than half of the patients in MSSP ACOs are women (58.8%). However,
because the data in the present study only analyzed the subpopulation of patients in the MSSP
ACO who underwent THA and TKA procedures, my findings cannot be generalized to all
patients in the MSSP ACO. A potential reason why there may be more female patients who
underwent THA and TKA procedures in the MSSP ACO than male patients is that most
Medicare beneficiaries are women (Owens, 2008). There could also be more female patients
undergoing THA and TKA procedures because there are just more of them (Duffin, 2019). The
percentage within males undergoing THA and TKA procedures in the physician-led MSSP ACO
could also be lower than the percentage within females who received these orthopedic
procedures.
Studies have also found that women visit physicians for hip and knee musculoskeletal
(MSK) disorders more often than men and are also more likely to undergo total joint arthroplasty
procedures than men (Maradit et al., 2014; Mota et al., 2012; Katz et al., 1996). Thus, another
potential reason why there may be more women than men undergoing THA and TKA procedures
in the MSSP ACO is that these women are experiencing greater and more severe MSK disorders,
which may cause them to seek more of these procedures than men. However, the data in the
present study do not allow me to make any conclusions about whether women generally
experience more severe MSK disorders than men. Also, the number of patients who were part of
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the MSSP ACO and received THA and TKA procedures was less likely to be male and more
likely to be female than the geographical area where the MSSP ACO is located.
My findings also conflict with other researchers’ findings. Studies have reported that
physicians, specifically orthopedic surgeons, are more likely to recommend total joint
arthroplasty procedures to male patients than female patients (Al-Taiar et al., 2013; Hame &
Alexander, 2013; Hawker et al., 2000; Novicoff & Saleh, 2011). The present study does not
provide the total number of male and female patients that visited the treatment-recommending
MSSP ACO physicians. Therefore, I could not determine whether men had a greater likelihood
than women to be recommended for THA and TKA procedures. Other studies have found that
physicians refer women less often than men for specialty care (Borkhoff et al., 2008; Franks &
Clancy, 1997).
Even though my data indicate that female patients undergo more THA and TKA
procedures than male patients in an MSSP ACO, the higher rate of utilization of these surgical
procedures does not consider the higher rate of prevalence of MSK disorders in women.
According to Hawker (2000), 44.9 per 1,000 women, and 20.8 per 1,000 men have a potential
need for total joint arthroplasty in the U.S. However, when these researchers considered patients
who were willing to undergo total joint arthroplasty, the number of surgical candidates decreased
to 5.3 per 1,000 women and 1.6 per 1,000 men. While their data indicate high underuse of total
joint arthroplasty for both men and women, the underuse is three times higher in women than in
men (O'Connor, 2006; Novicoff & Saleh, 2011). Judge et al. (2010) also found that men are
more likely to receive greater provision of THA and TKA services relative to their needs when
compared to women. To clarify, the study only analyzed patients undergoing THA and TKA

61

procedures who were part of an MSSP ACO. Thus, the findings from this study cannot be
generalized to all women and men.
PHDS RISK STRATIFICATION SCORE
Turning to the Predicting Hyperglycemic Crisis Death (PHDS) risk stratification scores
shown in Table 3, male patients had higher PHDS scores compared to female patients for all
years analyzed (2016-2018). However, it is important to note that my study was not able to
provide a PHDS risk stratification score before the THA and TKA procedures were performed
on the MSSP ACO patients. Having a patient’s PHDS risk stratification score pre-surgery would
have allowed me to analyze if the surgical intervention improved the patient’s degree of health.
Lim et al. (2015) found that TKA surgery improved male and female patients’ functional status.
Also, having a pre-operative PHDS score would have allowed me to analyze whether male or
female patients are sicker at the time of receiving THA and TKA procedures. Endo et al. (2014)
found that men were more likely to have a greater American Society of Anesthesiologists (ASA)
rating than women, indicating that men have more severe medical comorbidities than women at
the time of THA surgery. However, Lim et al. (2015) found that women had poorer preoperative
knee flexion compared to men. Future research is recommended to see whether there are
sex/gender-specific differences in pre-operative status for THA and TKA procedures between
male and female patients. Due to the lack of available data, the present study fails to analyze
whether male or female patients are sicker before receiving THA and TKA procedures and
whether these surgical interventions improved patients’ overall health and well-being.
As mentioned previously in the “Methods” section, the variables used to calculate the
PHDS score were diagnoses, hospital admissions, length of stay in days, readmissions, ED visits,
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age, drug or alcohol abuse, and behavioral health. Thus, a higher PHDS risk score suggests that
male patients undergoing THA and TKA procedures are more unhealthy and have worse
postoperative outcomes than that of female patients undergoing the same orthopedic procedures.
Also, a higher PHDS risk score may indicate that male patients who have undergone THA and
TKA procedures are at an increased risk of rehospitalization. However, because I do not know
exactly how each variable was weighted in the PHDS algorithm, I can only speculate on which
variables may have caused the higher PHDS score in men. Other studies in the literature support
the finding that men have worse outcomes than women after receiving THA and TKA
procedures.
According to a study presented at the 2015 Annual Meeting of the American Academy of
Orthopaedic Surgeons (AAOS), women fare better than men following THA and TKA
procedures. The researchers found that following surgery, men were 15% more likely to return to
the ED within 30 days of hospital discharge following either THA or TKA procedures, 60% and
70% more likely to have an acute myocardial infarction (heart attack) within three months
following THA and TKA procedures, respectively, 50% more likely to require a revision
arthroplasty within two years of receiving TKA procedures, and 25% more likely to be
readmitted to the hospital and 70% more likely to experience an infection or revision surgery
within two years of receiving TKA procedures, compared to women (Ravi et al., 2015). Lim et
al. (2015) found that women record greater improvements in pain and physical activity after
undergoing TKA procedures. Also, the American Academy of Orthopaedic Surgeons (2019) has
accepted as fact that male patients who sustain hip fractures have more comorbidities and higher
mortalities than female patients with hip fractures. The American Academy of Orthopedic
Surgeons has also reported that males who sustain hip fractures are more likely to sustain a
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secondary hip fracture and experience severe disability than female patients with hip fractures
(American Academy of Orthopaedic Surgeons, 2019).
Liebs et al. (2011) also established that women record better pain, physical function, and
stiffness scores in the short-term after receiving TKA procedures than men. Endo et al. (2004)
found that male patients were more likely to sustain medical complications (i.e., postoperative
pneumonia, arrhythmia, delirium, and pulmonary embolism) and had greater mortality rates one
year after receiving THA procedures than that of female patients. Other studies have also
observed that male hip fracture patients are sicker than female patients after receiving THA
procedures (White et al., 1987; Diamond et al., 1997; Fisher et al., 1991). Singh et al. (2013)
conducted a risk-adjusted analysis of post-TKA procedure complications from a sample of
elective primary TKA cases. These researchers found that compared to women, men had 48%
higher adjusted odds of one-year mortality after undergoing primary TKA procedures. Also, they
found that male patients were 31% more likely to develop surgical wound infections, 25% more
likely to be readmitted to the hospital within 30 days of receiving TKA procedures, and 20%
more likely to receive revision surgeries five years after receiving TKA procedures than that of
female patients. Heck et al. (1998) also found that male gender was a significant factor that
increased the likelihood of surgical revision within two years of receiving primary TKA
procedures.
However, my findings are not supported by other studies in the literature. Novicoff &
Saleh (2011) found that functional improvement after receiving total joint arthroplasty
procedures is comparable between male and female patients. Also, Mehta et al. (2015) did not
find any difference in the long-term post-treatment outcomes between men and women after
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undergoing TKA procedures. Lastly, Rolfson et al. (2009) observed that following THA
procedures, treatment outcomes were similar between men and women.
COST TO TREAT BENEFICIARIES
Looking at the total cost of care data shown in Table 4, we see that female patients
undergoing THA and TKA procedures were more costly to treat than male patients in the years
2016 and 2017. This finding seems to go against common intuition. As previously mentioned,
my results indicated that men who underwent THA and TKA procedures were more ill than
women undergoing these same procedures in the MSSP ACO. Thus, one would expect that a
sicker patient is a more costly patient. However, my findings seem to indicate the opposite; that
is, female patients who underwent THA and TKA procedures in the MSSP ACO are more
expensive to treat than male patients receiving these same procedures. The higher total costs of
care and lower PHDS scores for women undergoing THA and TKA procedures than men may be
explained by the fact that women are seeking more health services than men. Women being more
proactive in seeking health care services could make them healthier than their male counterparts.
In health care, women often are the primary decision-makers regarding selecting the source of
care (Berkowitz, 2019). A 2008 American Academy of Family Physicians national survey found
that 90% of women were responsible for health care decision-making for themselves and their
family members. Also, women with children under the age of 18 are more likely than their
husbands to select their child’s physician, take their child to doctor’s appointments, ensure their
children receive recommended care, and make decisions about their children’s health insurance
(Salganicoff et al., 2005). Increasingly, women want to play a strong role in their health care
decisions (Arora & McHorney, 2000). Earlier findings that women are significant contributors to
total medical costs have been cited in many studies.
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A study conducted by Hawker et al. (2000) concluded that although both men and
women underutilize arthroplasty, the underuse in women imposes a larger financial burden on
the government, insurance companies, individuals, and society than men. These researchers
explain that underutilization of arthroplasty in women exacerbates their musculoskeletal (MSK)
conditions; thus, needing more treatment later. Gupta et al. (2005) found that women are more
likely to report costs associated with osteoarthritis than men, especially women in rural areas.
Bertakis (2000) found that women had greater medical costs for primary care, specialty
care, emergency treatment, diagnostic services, and total annual charges compared to men.
Interestingly, she also found that there was no statistically significant difference in the number of
hospitalizations or hospital charges between male and female patients. An analysis of an
integrated database containing information on medical and pharmacy claims revealed that
women contributed to 60% of medical spending and consumed 59% of the prescription volume
(McNamara, 2001). Data from the Medical Expenditure Panel Survey (MEPS) between 1999 and
2001 showed that among privately insured seniors, women spent 17% more per person per year
on prescription drugs than men ($1,178 vs. $1,009) (Correa-De-Araujo et al., 2005).
Woolhandler & Himmelstein’s (2007) analysis of the 2003 MEPS data showed that in the
adult population aged 18-64 years, the medical spending per patient was $847 for men and
$1,844 for women. McNamara (2001) report that women’s reproductive health encompasses
16% of overall health plan costs, which is more than cardiovascular disease, diabetes, and
asthma combined; thus, female patients may be more expensive to treat because women may
require reproductive care. Bertakis (2000) found that women visited their primary care providers
and used more diagnostic services than men; thus, women may be more costly because they
utilize more physician services. Muller (1990) observed that women have more episodes of acute

66

illness and need more long-term care over their longer lifespans than men, which could
potentially explain why women have greater total costs of care compared to men.
Another plausible explanation for the higher total cost of care for female patients is that
women have lower social support than men (Demiralp et al. 2019). It is important to note that the
data in the present study do not indicate that women have lower social support than men; this is
just pure speculation on why women undergoing THA and TKA procedures in the physician-led
MSSP ACO have greater total costs of care than men. This lower social support could add other
additional health care expenses; female patients would not only have to pay the direct cost of
their surgery but must hire caregiving services to carry out household roles during recovery from
surgery. With this understanding of the costs of surgery, women may incur higher costs to
undergo THA and TKA procedures, even if the direct costs of operation are standard for both
male and female patients. However, the present study could not separate indirect costs from the
direct costs for patients undergoing THA and TKA procedures in the MSSP ACO. Thus, the
present study cannot form any conclusions on whether female patients have greater indirect costs
from surgery than men in the MSSP ACO. Future research is recommended to see if the cost
associated with caregiving services could cause sex/gender-specific differences in patients’ total
costs of care.
It is important to note that in 2018, female patients undergoing THA and TKA
procedures became less costly to treat than male patients (Table 4). A potential explanation for
this phenomenon could be that this physician-led MSSP ACO emphasized the management of
postmenopausal women. This point was made because the data shown in Table 4 and Figure 8
indicate a greater drop in female patients’ total cost of care than that of male patients (18.4% vs.
5.66%).
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In addition to quantitatively depicting the difference in costs between male and female
patients undergoing THA and TKA procedures, the data shown in Table 4 and Figure 4 show a
trend of decreasing total cost of care to treat each patient in the MSSP ACO. As mentioned in the
“Results” section, between 2016 and 2018, male patients’ total costs of care decreased by 5.66%,
female patients’ total costs of care decreased by 18.4%, and the cost associated with treating the
average patient in the MSSP ACO decreased by 14.2%. This trend is also seen when patients
were categorized by insurance status (i.e., Medicare-only patients vs. dual-eligible patients).
Specifically, between 2016 and 2018, Medicare-only patients’ total costs of care decreased by
11.47%, and dual-eligible patients’ total costs of care decreased by 20.7%.
These significant decreases in the total cost of care for patients provide key evidence that
shows that this physician-led MSSP ACO located in the western U.S. is fulfilling its role as a
health cost-reducer. To reduce patients’ total costs of care, this physician-led MSSP ACO
adopted a significant patient coordinated care system that required the MSSP ACO medical
director or nurse case managers to monitor, among multiple factors, hospital bed days, optimized
use of post-operative skilled nursing facilities (SNFs), and aggressive management of patients’
comorbid conditions.
According to the Centers for Medicare and Medicaid Services 2019 Care Coordination
Toolkit, MSSP ACOs have been collaborating with SNFs to provide their beneficiaries with
efficient, proper post-acute care. To support care-coordination efforts with SNFs, MSSP ACOs
have established networks of high-performing SNFs, engaged SNFs in care-coordination
processes, and have identified staff to support beneficiaries’ care transitions to SNF (Centers for
Medicare and Medicaid Services, 2019a).
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Other strategies have been cited in the literature that MSSP ACOs use to better transition
to value-based care. According to Kraus (2019), the top twenty MSSP ACOs have adopted three
main strategies to lower Medicare spending and improve patient care quality. These shared
practices include encouraging patients to be more active in their care, helping chronically ill
patients better manage complex conditions, and reducing avoidable hospitalizations. To support
patient decision-making, an MSSP ACO developed an SNF scorecard (Appendix 3). As seen in
Appendix 3, this scorecard provides MSSP ACO beneficiaries with information on SNF
performance on measurable outcomes (i.e., preventing rehospitalization, improving patient
independence, and reducing length of stay)
Research analyzing the cost-savings of MSSP ACOs and publicly published data seems
to corroborate my findings. Studies report that overall, the MSSP has reduced spending and
improved quality of care compared to FFS Medicare (Department of Health and Human
Services, 2017; McWilliams et al., 2018). Other studies have found that compared to non-ACOs,
the MSSP ACO model is associated with reduced post-acute care and SNF stays (McWilliams et
al., 2017), reduced admissions (Winblad et al., 2017), and improved patient experiences
(McWilliams et al., 2014). According to CipherHealth.com (2019), from the Medicare Shared
Savings Program (MSSP) alone, 60% of participating MSSP ACOs have generated over $1
billion in savings for CMS. After sharing the savings back with the MSSP ACOs, CMS saved
$313.7 million in savings. Also, Epstein et al. (2014) found that patients who were part of an
MSSP ACO had 5.8% lower total costs of care than patients who were not part of an MSSP
ACO ($7,694 vs. $8,164). Multidisciplinary health care teams that coordinate care and monitor
patient recovery, like MSSP ACOs, may improve patient satisfaction, improve efficiencies, and
reduce readmissions (Barbieri et al., 2009; Burnham et al., 2017; McLawhorn et al., 2017).

69

Lastly, Parasrampuria et al. (2018) found that MSSP ACOs are a mechanism for decreasing costs
by improving the quality of care.
Even though there is evidence that MSSP ACOs do reduce the total cost of care for their
beneficiaries, Markovitz et al. (2019) concluded that MSSP ACOs do not decrease costs or
improve the quality of patient care. One possible explanation is that MSSP ACO’s do not have
the ability to prohibit out-of-network care, which limits their control over spending (Lin et al.,
2020). Additional studies need to be conducted to analyze whether MSSP ACOs are true health
cost reducers. Reducing healthcare costs is of utmost importance. Growth in medical spending
has caused stagnant wage growth for many people and is squeezing public and private resources
that could be devoted to other priorities such as education and infrastructure (Altman &
Mechanic, 2018).
Also, the data shown in Table 5 indicate that patients with only Medicare insurance have
lower total costs of care than dual-eligible patients over the period between 2016 and 2018. Data
from the Kaiser Foundation Commission on Medicaid Facts (2011) indicate that Medicare and
Medicaid spending averaged $20,000 per dual-eligible patient, which was about five times
greater than spending on other Medicare beneficiaries. Also, Cylus et al. (2011) observed that
patients 65 years or older with Medicare insurance had lower health expenditures than those with
Medicaid insurance. It is important to note that the patients who only have Medicare insurance
have a 20% co-insurance payment that they are responsible for paying while dual-eligible
patients do not have the 20% co-insurance payment. Dual-eligible patients do not have any outof-pocket expenses when they utilize medical services. Specifically, Medicaid pays their
Medicare Part B premiums (Medicare Part B premiums were $96.40for most beneficiaries in
2010), pays their out-of-pocket payments charged for many Medicare services, and covers
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critical benefits Medicare does not cover, such as long-term care, dental care, and eyeglasses
(Kaiser Commission on Medicaid and the Uninsured, 2011). Thus, the total cost of care for
Medicare-only patients may be lower than that of dual-eligible patients because Medicare-only
patients are foregoing health services because of their associated out-of-pocket expenses.
However, this study cannot deduce whether Medicare-only patients are foregoing health
services. Claxton et al. (2019) have shown that high health care costs can be a barrier for
patients to access care in the U.S. Their survey data indicated that about 1 in 10 adults report
having delayed foregoing any medical care because of its cost. Also, Ackerman, Livingston, &
Osborne (2016) observed that patients did not undergo THA and TKA procedures due to cost
barriers.
Dual-eligible patients’ higher level of health care spending could also reflect their greater
health needs and utilization of services compared to patients with only Medicare insurance.
Dual-eligible patients represent low-income seniors and younger people with disabilities
(Appendix 4). They are among the sickest and poorest patients covered by either Medicare or
Medicaid programs (Kaiser Commission on Medicaid and the Uninsured, 2011). Recent
estimates show that dual-eligible patients account for a disproportionate portion of spending in
both Medicare and Medicaid (Rousseau et al., 2010). In 2005, dual-eligible patients’ combined
Medicare and Medicaid spending totaled nearly $200 billion (Kaiser Commission on Medicaid
and the Uninsured, 2011). The Kaiser Commission on Medicaid and the Uninsured (2011) found
that most dual-eligible patients have very low-incomes: 55% of them have an annual income
below $10,000 compared to 6% of all other Medicare beneficiaries (Appendix 5). Also, dualeligible patients have more substantial physical and mental health needs, more likely to have
attained less than a high school education, more likely to be a member of a racial or ethnic
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minority, have a greater tendency of living in nursing homes compared to other Medicare
beneficiaries (Kaiser Commission on Medicaid and the Uninsured, 2011) (Appendix 5). Dualeligible patients are also more likely never to have been married (Coughlin, Waidmann, &
Phadera, 2012). Because dual-eligible patients have significant medical needs, they may have
much higher per capita costs than patients with only Medicare insurance. Previous studies have
also shown that dual-eligible patients differ from Medicare-only patients in many ways.
In summary, the present study shows that 1) male patients have worse postoperative
outcomes after undergoing THA and TKA procedures than female patients, 2) female patients
undergoing THA and TKA procedures have greater total health care costs than that of male
patients receiving the same surgical interventions, and 3) this physician-led MSSP ACO has been
successful in decreasing the total cost of care for its patients undergoing THA and TKA
procedures. Since this MSSP ACO has demonstrated significant cost-reductions for female
patients undergoing THA and TKA procedures in a three-year period, female patients
undergoing these two procedures may be prime targets for healthcare organizations looking to
reduce health care costs. Also, because male patients undergoing THA and TKA procedures
were found to be more unhealthy than female patients, male patients undergoing these orthopedic
procedures may be a critical population for healthcare organizations to focus on to improve postsurgical outcomes. This will be of importance as the health care reimbursement system shifts
from an FFS model to a value-based model.
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CHAPTER 5: CONCLUSION
The present study’s results have implications from a clinical perspective as well as from
an economic standpoint. The knowledge that men are more ill and have a greater likelihood of
developing unintended outcomes after receiving total hip arthroplasty (THA) and total knee
arthroplasty (TKA) procedures identifies a subpopulation of THA and TKA patients who may
benefit from closer monitoring during the perioperative period. This will become particularly
important as the number of THA and TKA patients continues to escalate, and as increased
pressure is placed on healthcare organizations and systems to contain health costs in all aspects
of the healthcare arena.
The present study also found that there were deviations in the total costs of care for
patients undergoing THA and TKA procedures in an MSSP ACO depending on their sex/gender
and insurance types. I observed that female patients undergoing THA and TKA procedures had
greater total costs of care than male patients undergoing the same procedures between the years
2016 and 2017; however, in 2018, female patients were found to be less costly than male
patients. The data from the present study also indicated that Medicare-only patients were less
costly to treat than dual-eligible patients. Thus, the present study has possibly highlighted two
subpopulations of patients undergoing THA and TKA procedures that are high-cost patients.
Managing the care of these high-cost patients is a key concern of physicians and health
systems that are forming MSSP ACOs, where reimbursement is tied to performance on cost
reductions and quality measures (Yongkang et al., 2020). It is recommended that MSSP ACOs
adopt high-risk care management programs, which involve coordinating additional resources and
health services toward high-cost patients (Powers & Chaguturu, 2016). Care management
programs adopted by MSSP ACOs have taken many different forms and are aimed to target
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specific populations of patients. The following section will discuss two care management
programs that have been implemented by MSSP ACOs.
CARE MANAGEMENT PROGRAM: EXAMPLE #1
Multiple MSSP ACOs in the U.S. have focused on ways to encourage care coordination
in the ED. One strategy MSSP ACOs have developed to meet this goal is to plant care managers
within the ED to provide their beneficiaries with timely coordination (Centers for Medicare and
Medicaid Services, 2019a). These MSSP ACOs rely on these embedded care managers to drive
collaboration between ED clinicians and primary care providers (Centers for Medicare and
Medicaid Services, 2019a). These embedded care managers have access to patient information
detailing their previous health needs from the electronic health record (EHR) and share this
critical information with ED clinicians. Embedded care managers are also able to assist with
patient discharges and transfer from the ED to another care setting or the patient’s home (Centers
for Medicare and Medicaid Services, 2019a).
CARE MANAGEMENT PROGRAM: EXAMPLE #2
An MSSP ACO in the U.S. developed a care management program designed to reduce
admissions among its beneficiaries with chronic respiratory cardiac conditions. In this care
management program, the MSSP ACO’s inpatient care manager communicates with an
ambulance service partner, who sends staff to the beneficiary’s home within a day of discharge
from the hospital to conduct a home safety evaluation. The MSSP ACO staff checks if these
beneficiaries have filled their prescriptions, have nebulizers and other equipment necessary to
manage their present condition. The staff also checks if the beneficiary understands his/her postdischarge instructions. The MSSP ACO will also send its respiratory therapist to visit the
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beneficiary in their homes to talk to them about ways to effectively self-manage his/her
condition. The therapist also confirms that the beneficiaries are receiving ongoing care from a
primary care physician or pulmonologist, have an emergency medicine pack in their homes, and
know about a dedicated telephone number that the MSSP ACO operates for beneficiaries with
chronic pulmonary obstructive disorder (COPD). If beneficiaries call this number, they will be
connected to MSSP ACO staff that will assess their needs and connect them to a population
health coach, a primary care physician, or the ED if there is a true emergency (Centers for
Medicare and Medicaid Services, 2019a).
The adoption of high-risk care management programs could substantially reduce costs
and improve patients’ quality of care. According to the Centers for Healthcare Strategies (2007),
care management is a promising team-based, patient-centered approach “designed to assist
patients and their support systems in managing medical conditions more effectively.” However,
because high-risk patients in an MSSP ACO can be a heterogeneous subpopulation, a one-sizefits-all approach may not be effective in decreasing total costs of care and improving the quality
of care. Thus, a diversified approach tailored to the clinical realities of target populations is
needed for MSSP ACOs to manage the care of their high-cost subgroups. There are implications
for health systems, payers, and physicians.
Health systems, no matter their experience levels with alternative payment models, who
are assuming responsibility for new patient populations, will require a thorough knowledge of
the clinical characteristics and care-utilization patterns of their high-risk subgroups and the
identification of evidence-based programs for managing their care. Because there will be a need
for large up-front investments to identify high-risk groups and evidence-based programs, payers
need to understand that demonstrated proficiency in caring for specific high-risk populations by
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an MSSP ACO does not remove the need for contracts to provide adequate financial incentives
to support investments in new care-management capabilities. Physicians in MSSP ACOs also
have a critical role in engaging their patients and matching them with specific evidence-based
programs according to their clinical needs. Furthermore, front-line clinicians can assist health
care leaders to identify and test new strategies for high cost-patients and provide insights into
care needs at a level of granularity that cannot be gleaned from electronic health data.
Lastly, my study showed that this physician-led MSSP ACO located in the western U.S.
has been successful at significantly reducing the total cost of care for its patients receiving THA
and TKA procedures between the years 2016 and 2018. This finding indicates that MSSP ACOs
can be successful at reducing the total cost of care for its patients and show promise in
decreasing health care costs and increasing health care quality. Based on the cost-data collected
in the present study, it is recommended that MSSP ACOs should be supported and expanded to
decrease health care costs. However, MSSP ACO’s ability to continue to reduce health costs and
improve patients’ quality of care is dependent on their survival in the current healthcare
marketplace.
To survive in today’s value-based healthcare arena, MSSP ACOs need to adopt
innovative organizational practices to decrease their spending and realize increased profits.
MSSP ACOs may need to control their beneficiaries' use of out-of-network primary care
physicians. Lin et al. (2020) found that patients’ use of out-of-network primary care was
associated with an increase of $10.79 in quarterly total MSSP ACO spending per patient. Thus,
MSSP ACOs might realize more savings if its incentives its patients to seek primary care within
its network. For example, MSSP ACOs could lower copayments for primary care physicians
within their network.
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Future policies aimed at helping MSSP ACOs control their level of out-of-network
primary care may also help them lower spending and increase revenues. Policies aimed at
expanding the MSSP ACO Beneficiary Program, which allows certain MSSP ACOs to pay
beneficiaries a financial incentive to receive primary care within their network, could potentially
help MSSP ACOs realize more cost savings (Schulz, DeCamp, & Berkowitz, 2015). However, it
is important to note that these incentives would need to be balanced with the protection of patient
choice, which is a defining feature of MSSP ACOs. Policymakers should also consider
providing data on out-of-network care utilizations to MSSP ACOs to help them identify reasons
why their beneficiaries are seeking primary care services out of their network. Also, policies
could be enacted to provide training and resources to encourage MSSP ACOs to offer telehealth
services in line with those covered under the Bipartisan Budget Act of 2018, which allows MSSP
ACOs to expand the use of telehealth services (Shwartz, 2018). Increasing telehealth service
capabilities could potentially allow MSSP ACOs to decrease the number of their beneficiaries
accessing primary care services out of their network.
In December 2018, CMS released its Pathways to Success rule, which completely
overhauled the MSSP. The policies outlined in this new rule provide a new direction for the
MSSP by redesigning the participation options available under this program to encourage MSSP
ACOs to transition into two-sided models, which means MSSP ACOs may share in savings and
are also responsible for repaying shared losses (Centers for Medicare and Medicaid Services,
2018a). Why did CMS propose this rule? According to the CMS program data, MSSP ACOs
taking on downside risk perform better than those who do not. Specifically, their data showed
that MSSP ACOs taking on downside risk showed an average reduction in spending relative to
their targets of $96 per beneficiary, compared to $68 for MSSP ACOs that did not take on
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downside risk (Verma, 2019). According to CMS (2018), “these policies are designed to increase
savings for the Trust Funds and mitigate losses, reduce gaming opportunities, and promote
regulatory flexibility and free-market principles. This final rule also provides new tools to
support coordination of care across settings and strengthen beneficiary engagement and ensure
rigorous benchmarking.” Appendix 6 outlines what changes the Pathway to Success rule has
finalized for MSSP ACOs.
However, the Pathways to Success rule and its associated provisions affect a healthcare
organization’s decision to begin or continue participating in an MSSP ACO. I believe that the
MSSP could benefit from an adjustment to one of its key components to better support MSSP
ACOs: the timing of moving MSSP ACOs into down-sided risk, which means MSSP ACOs are
responsible for financial losses with payers if the MSSP ACOs fail to meet their target
benchmarks. Bleser et al. (2019) observed that MSSP ACOs taking on downside risk have higher
rates of exit from the MSSP. One of the implications of the 2018 Pathways to Success rule is that
MSSP ACOs have only one to three years before moving to a two-sided risk model, which is
considerably less than the current six years (Appendix 6). Thus, less time for MSSP ACOs to
transition to a two-sided risk model could cause them to drop out of the MSSP.
Interestingly, Bleser et al. (2019) also found that the likelihood of MSSP ACOs dropping
out of the MSSP decreases after the first three years of joining this government program. This
may suggest that MSSP ACOs need at least three years to adjust to the MSSP and begin making
changes in their health care delivery practices to accept downside risk. Policymakers may need
to increase the amount of time before MSSP ACOs move into a two-sided risk model to better
support MSSP ACOs in this value-based healthcare landscape.
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Considering the present study’s findings, there needs to be an increased focus and
emphasis on improving male patients’ outcomes after receiving THA and TKA procedures in
MSSP ACOs. One way MSSP ACOs can improve their beneficiaries' outcomes after receiving
THA and TKA procedures is to dedicate staff to coordinate care with SNFs. According to the
Centers for Medicare and Medicaid Services (2019a), MSSP ACOs have designated a team of
care managers to work with SNF staff through telephone calls and in-person visits. Once a
beneficiary has been admitted to an SNF, care managers work with the SNF staff to streamline
the beneficiary's transition to this new SNF setting and enable the beneficiaries to receive timely
therapy, which could potentially improve patient outcomes. An MSSP ACO who integrated this
strategy stated that “the care manager’s involvement is particularly impactful in the first 30 days
of the beneficiary’s SNF stay because it ensures that the care plan reflects the health needs
identified by primary care and inpatient clinicians who have treated the beneficiary in the past”
(Centers for Medicare and Medicaid Services, 2019a, pg. 7)
Another strategy to help improve the post-surgical outcomes of male patients undergoing
THA and TKA procedures, orthopedic surgeons, hospitals, and multidisciplinary health care
teams need to incorporate more technology in their delivery of care. MSSP ACOs can leverage
their EHRs to address social determinants of health. According to the Centers for Medicare and
Medicaid Service (2019), an MSSP ACO improved its EHR to help them streamline the referral
process to community partners. Appendix 6 describes the details of this specific strategy
developed by the MSSP ACO. The updated EHR system has the capability of identifying a
patient’s unmet needs that are related to social determinants of health. The MSSP ACO’s care
coordinator used this EHR to create a referral to a social worker within the practice. Also, the
MSSP ACO’s EHR had the ability to generate direct referrals to community partners. Electronic
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health data can be used to improve the health statuses of patients undergoing THA and TKA
procedures.
Healthcare organizations and providers may also be able to improve their THA and TKA
patients’ health statuses and reduce unnecessary costs and complications by integrating mobile
and web-based technologies into their delivery of (Feng et al., 2018). Sloan et al. (2018) found
that the average age for patients undergoing THA has decreased from 66 years to 64 years and
decreased from 68 to 66 years for patients undergoing TKA procedures. This decreased average
age for patients undergoing these orthopedic procedures may indicate a population of patients
who are more physically active and more technologically adept than patients in the past. Also,
Anderson & Perrin (2017) found that the adoption of technology and internet usage among the
senior citizen population has grown drastically within the past five years. They also found that
almost half of the senior citizen population aged 70 to 74 years in the U.S. own smartphones, and
75% use the internet. Among those who were 65 to 69 years of age, nearly 60% own
smartphones, and 82% reported using the internet regularly (Anderson & Perrin, 2017). This
evidence shows that the patient population may be receptive to healthcare organizations and
clinical providers, increasing the amount of technology in their delivery of patient care.
When the delivery of care is coupled with smartphones, web-based, and other mobile
communications, patients may have better health outcomes, and the cost of care may be reduced.
The methods of communication would allow patients to connect to their care teams (Burnham et
al., 2017; Semple & Armstrong, 2017). Also, innovations in electronic information sharing and
communications technologies have allowed orthopedic surgeons, hospitals, and multidisciplinary
health care teams to better collaborate and share information with THA and TKA patients and
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other health care team members across various platforms throughout the patient care continuum
(Semple & Armstrong, 2017).
Smartphone capabilities such as texting, photo-taking, and web-based interfaces may
enhance patients’ transitions of care from the hospital to their homes, allow patients to
communicate their symptoms in text and pictures, and may promote patients to be actively
engaged in their recovery after receiving surgery (Mosa et al., 2012; Semple & Armstrong,
2017). Also, online patient engagement portals that are accessible via smartphones, internet, or
tablets, may reduce health costs by three mechanisms: replacing in-person follow-up visits,
providing discharge instructions to patients and their families, and alerting health care teams to
complications during the patient’s recovery period (Mosa et al., 2012; Semple & Armstrong,
2017). Increasing the amount of technology in the delivery of patient care can also potentially
play an important role in maximizing communication between patients and their providers
throughout all points of the care continuum by helping prepare patients for surgery, sharing
health information during the hospital stay, and conveying real-time updates on medication, pain
control, and rehabilitation protocols at key stages during the recovery period (Fingar et al., 2016;
Semple & Armstrong, 2017).
Jayakumar et al. (2017) have observed that patients who received total knee and hip
arthroplasty procedures and who enrolled in web-based preoperative education and participated
in technology-based programs that encourage increased patient communication and engagement
from the preoperative stage through the post-discharge phase, had reduced lengths of stays,
decreased costs, and reported having better experiences with their care.
Lastly, wearable devices that contain sensors to monitor patients’ movements and posture
are being promoted by companies to improve patients’ rehabilitation following THA and TKA
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procedures. However, a review conducted by Bahadori et al., 2018 concluded that there is very
little evidence that supports the notion that wearable devices improve patient outcomes following
THA and TKA procedures. It is important to note that these researchers also concluded that these
wearable devices show promise in improving patient outcomes after receiving THA and TKA
procedures, the implementation of these devices is feasible, and that the devices are safe for
patient use.
CMS has seen the promise technology can play in reducing patients’ length of stay days,
decrease their costs, and increase patient satisfaction with their care. CMS has introduced two
new codes for physician services to reimburse health care providers for using technology in their
delivery of patient care. These new codes will allow CMS to pay separately for two newly
defined physicians' services using communication technology: “brief communication
technology-based service” (e.g., virtual check-in) and “remote evaluation of recorded video
and/or images submitted by an established patient” (Centers for Medicare and Medicaid
Services, 2018b). Thus, health care providers can be separately paid for the “brief
communication technology-based service” service when their patients check in with their
provider via telephone or other telecommunications device to decide whether an office visit or
other service is needed. CMS believes that adopting technology in the delivery of patient care
would increase not only the efficiency for physicians but also increase convenience for patients.
Also, the “remote evaluation of recorded video and/or images submitted by an established
patient” service would allow physicians to be paid separately for reviewing patient-transmitted
photo or video information to assess whether a visit is needed.
Incorporating more technology into healthcare delivery is also expected to benefit female
patients undergoing THA and TKA procedures. The adoption of more technology in patient care
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has already shown the potential to improve women’s quality and access to medical care. This can
be evidenced by Maven Clinic, a telehealth company for women and families. Maven Clinic
works with hundreds of providers that are inside and outside of the traditional medical system,
including lactation consultants, midwives, family physicians, obstetricians, and pediatricians to
provide on-demand 24/7 access to health care providers for their members. To communicate with
providers, members can use video chat or direct message healthcare practitioners using the
Maven app. Maven Clinic’s maternity service is available 24/7 for women couples who have
questions about their health and their newborn’s health.
Another company that has revolutionized women’s health care with its technology is
Clarius Mobile Health, which has developed wireless handheld ultrasound scanners that can be
accessed from a smartphone. Their ultrasound scanners can deliver high-resolution ultrasound
images traditionally only available with bulkier, high-end systems. These portable ultrasounds
can benefit women’s maternal care, emergency healthcare, biopsies, and regional anesthesia
(Powell, 2018). Portable ultrasound technology can be used in communities where there are
remote and underfunded clinics to improve patients’ access and quality of pregnancy care,
preventative treatment, and emergency care.
Artificial intelligence (AI) has also shown promise to advance women’s health.
Researchers at Lehigh University developed an AI algorithm to identify cervical dysplasia that
could replace expensive equipment needed to run tests like Pap smears and HPV tests (Powell,
2018). According to the latest world cancer statistics (Ferlay et al., 2015), cervical cancer is the
fourth most common cancer in women globally (528,000 new cases each year) and the second
most common in developing areas (445,000 new cases each year). Cervical cancer is also the
fourth most lethal cancer in women worldwide (266,000 deaths) and the third cause of cancerrelated death in developing countries (230,158 deaths) (Ferlay, 2015), which means that more
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than 80% of the global burden occurs in developing areas. To address this epidemic, Lehigh
University’s AI algorithm can improve access and quality of medical care and decrease health
costs for women in low-resource areas.
Furthermore, studies have shown that women from underserved communities do not
adequately use mammograms (DeSantis et al., 2017; Berg et al., 2004). For example, African
American mammographic screening rates are 19% lower than rates for non-Hispanic White
women (Ahmed et al., 2017), and women living in high-poverty areas are 50% less likely than
women living in higher-income areas to have received a mammogram in the previous two years
(Calo et al., 2016). Considering this problem, two researchers at Drexel University’s School of
Biomedical Engineering, Science and Health Systems developed iBreastExam, a hand-held,
battery-operated tool to detect breast cancer without radiation. The iBreastExam provides results
within minutes, through its paired mobile app. The iBreastExam device has reduced costs
considerably, to between $1 and $4 per exam, rather than the $20 that a mammogram costs in
India (Powell, 2018).
Lastly, mobile phones and mobile health programs can improve women’s access to
healthcare. Mobile health programs can be used to remind patients of their appointments, provide
remote consultations, ease access to health clinics, improve communication with local health
workers, and track information during and after pregnancy, such as infant growth. Evans et al.
(2012) analyzed the efficacy of a mobile health program called Text4baby, which delivers text
messages to underserved pregnant women and new mothers to change their health, health care
beliefs, practices, and behaviors to improve clinical outcomes. Evans et al. (2012) randomized
participants, who were all pregnant women first presenting are, to enroll in theText4baby
program. They surveyed these women before enrolling in Text4baby (baseline) and after
enrolling in this program, which was approximately 28 weeks of baby’s gestational age(followup).
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Interestingly, the researchers found a significant effect of Text4baby intervention
exposure on increased agreement with the attitude statement “I am prepared to be a new mother”
between baseline and follow-up. For those who had attained a high school education or greater,
they observed a significantly higher overall agreement to attitudes against alcohol consumption
during pregnancy and observed a significant improvement of attitudes toward alcohol
consumption from baseline to follow-up. Thus, mobile health programs such as Text4baby may
be a promising program to improve the quality of female patients’ care.
LIMITATIONS AND FUTURE AREAS OF RESEARCH
This study was subjected to the following limitations. First, my study did not conduct
formal statistical analyses to see if there was a true difference in the PHDS risk scores and the
average total costs of care between male and female patients undergoing THA and TKA
procedures. If statistical analyses on these data were possible in the present study, I would have
used the Student’s t-test. This statistical method is commonly used by researchers to examine
whether there are differences in patients’ costs of health care (Zhou et al., 1997). Also, Student’s
t-test would have allowed me to see if there was a statistically significant difference between the
male patients’ average PHDS risk stratification score and female patients’ average PHDS risk
stratification score. Knowing if there was a statistically significant difference between male and
female patients’ PHDS risk scores and total costs of care would have allowed me to conclude
that the differences found in these data were not attributed to sampling error.
Second, I could not determine what variable(s) in the PHDS risk stratification algorithm
caused the increased average PHDS risk score in male patients compared to female patients.
Because the PHDS risk stratification score algorithm is a proprietary formula used by the MSSP
ACO, I did not have access to how each variable was weighted in the algorithm. Therefore, I was
unable to see which variable affected the PHDS risk score the most, limiting my ability to
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speculate on the potential reasons why men had a greater risk score than women. Future
research is recommended to analyze why men are sicker than women after receiving THA and
TKA procedures. Do male patients have a greater likelihood of being admitted to the hospital?
Does the sex/gender of patients undergoing THA and TKA procedures affect their length of stay
days after receiving these procedures? Are there sex/gender-specific differences between men
and women in the number of hospital readmissions after receiving THA and TKA procedures?
Are there sex/gender differences in the rate of utilization of the ED? Are men or women more
susceptible to alcohol abuse and poor mental health?
Third, I did not collect the PHDS risk stratification score at different periods after the
MSSP ACO patients underwent THA and TKA procedures. Ideally, I would have collected the
patients’ PHDS risk stratification scores every month after they received THA and TKA
procedures for two years. This data-collection approach would have allowed me to see if there
were any changes in the PDHS risk stratification scores after the THA and TKA procedures were
performed. For example, these data would have allowed me to see if there was an equilibration
of PHDS risk stratification scores between male and female patients. Also, having access to
longitudinal PHDS risk stratification data would have allowed me to identify potential predictors
of persistent high-risk patients undergoing THA and TKA procedures. Chang et al. (2019) found
that urban residence, chronic medical comorbidities, auditory and visual impairment, chronic
pain, any cancer diagnosis, and social instability were predictors of patients being persistently
high-risk. These researchers also found that after two years, just 14% of the patients enrolled in
the Veterans Health Administration (VHA) remained high-risk for hospitalization. Papakostidou
et al. (2012) found that women recorded worse scores in the domains of pain and physical
activity than men six weeks after receiving TKA procedures, but the scores leveled out
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afterward. Other studies have also found that many high-need patients are just temporarily highrisk (Johnson et al., 2015; Wong et al., 2018; Yoon et al., 2018).
Fourth, the sample size in the present study was not representative of the general
population. Not only was the sample population not large enough, but it was also located in one
region in the western U.S. Thus, my findings may be tainted by geographic and regional
isolation. Future studies are recommended to look at multiple MSSP ACOs in different areas of
the U.S. to try to create a better representative sample of the general population.
Fifth, as mentioned previously, the present study does not provide the total number of
male and female patients that visited the treatment recommending MSSP ACO physicians.
Therefore, I could not determine whether a patient’s sex/gender affected the rate of MSSP ACO
physician’s recommending THA and TKA procedures. Studies have found that physicians refer
women less often than men for specialty care (Al-Taiar et al., 2013; Borkhoff et al., 2008; Franks
& Clancy, 1997; Hame & Alexander, 2013; Hawker et al., 2000; Novicoff & Saleh, 2011).
However, these studies do not analyze physician referral patterns in an MSSP ACO setting.
Thus, further research is recommended to see if sex/gender affects physicians' referral patterns
for THA and TKA procedures in MSSP ACO settings.
The study’s findings are timely, significant, and important. The finding that male patients
undergoing THA and TKA procedures in an MSSP ACO have an increased risk of developing
poor health after surgery identifies a subpopulation of THA and TKA patients who could benefit
from closer monitoring during the perioperative period. The knowledge that an MSSP ACO in
the western U.S. has been successful in reducing the health costs of its beneficiaries undergoing
THA and TKA procedures indicates that MSSP ACOs may have the ability to act as cost
reducers. Reducing healthcare costs is of utmost importance. Health care has accounted for a
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growing share of the Gross Domestic Product (GDP). According to the Centers for Medicare and
Medicaid Services (2019b), the health share of GDP is expected to rise from 17.8% in 2018 to
19.4% of GDP-or nearly one of every five dollars in the economy by 2027 (Appendix 8).
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Appendix 1. Representative Male and Female Bony Pelvis (Wang et al., 2004)

Appendix 2. The Institute for Healthcare Improvement’s Triple Aim (Institute for
Healthcare Improvement, 2020)
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Appendix 3. An MSSP ACO’s Implemented Strategy to Support its Beneficiaries' DecisionMaking by Developing an SNF Scorecard. (Centers for Medicare and Medicaid Services,
2019a)

Appendix 4. Dual-Eligible Patient Demographics, 2007 (Kaiser Commission on Medicaid
and the Uninsured, 2011)
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Appendix 5. Comparison of Dual-Eligible Patients and Other Medicare Beneficiaries, 2008
(Kaiser Commission on Medicaid and the Uninsured, 2011)

Appendix 6. CMS’s Pathway to Success Rule Changes (Centers for Medicare and Medicaid
Services, 2018a)
Category of
Change

Rule

Accountability
and Competition

“The final rule reduces the amount of time that an ACO can remain in the program without
taking accountability for healthcare spending from six years to two years for new ACOs
and three years for new “low revenue” (physician-led) ACOs, including some rural ACOs.
The rule also strengthens incentives by providing higher shared savings rates as ACOs
transition and accept greater levels of risk.”

Quality

Beneficiary
Engagement

Integrity

“To increase flexibility for ACOs taking on risk, Pathways to Success expands access to
high-quality telehealth services that are convenient for patients, including telehealth
services provided at a patient’s place of residence.”
“Pathways to Success promotes beneficiary engagement and improved health outcomes by
allowing ACOs to offer incentive payments to beneficiaries for taking steps to achieve good
health, such as obtaining primary care services and necessary follow-up care. In addition,
this rule requires ACOs to provide beneficiaries with a written explanation in person or via
email or patient portal of what it means to be in an ACO to put patients in the driver seat.”
“This rule established rigorous benchmarks by incorporating factors from regional
Medicare spending to establish an ACO’s benchmark during all agreement periods,
providing a more accurate point of comparison for evaluating ACO performance. In
addition, ACOs that terminate their participation will be accountable for prorated shared
losses.”
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Appendix 7. An MSSP ACO’s Implemented Strategy to Leverage its Electronic Health
Record to Address Social Determinants of Health (Centers for Medicare and Medicaid
Services, 2019a)

Appendix 8. Projected U.S. Healthcare Expenditures as a Percentage of Gross Domestic
Product (Patton, 2019)
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